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ABSTRACT
Anthrax is a lethal infectious disease caused by the bacterium Bacillus anthracis. B.
anthracis secretes the virulence factor anthrax lethal toxin (LeTx), which causes rapid cell
death known as pyroptosis and immune suppression in macrophages. Strikingly, RAW 264.7
macrophages pre-exposed to sub-lethal doses of LeTx become refractory to subsequent high
cytolytic doses. The phenomenon is termed toxin-induced resistance (TIR). TIR is in part
linked to the down-regulation of three mitochondrial death genes, BCL2/adenovirus E1B 19
kDa-interacting protein 3 (BNIP3), BNIP3-like (BNIP3L), and metastatic lymph node 64
(MLN64) protein, as well as the up-regulation of a gene-silencing epigenetic regulator,
histone deacetylase (HDAC) 8. Interestingly, I found that inhibiting HDAC8 with the
HDAC8-specific inhibitor PCI-34051 in RAW 264.7 TIR cells sensitized them to LeTxinduced pyroptosis. Furthermore, resistance to LeTx-induced pyroptosis is likely mediated
by HDAC8-dependent H3K27Ac deacetylation in the regulatory regions of the mitochondrial
death genes, BNIP3 and MLN64. Although, sub-lethal doses of LeTx induced resistance to
pyroptosis in RAW 264.7 macrophages, LeTx still caused immune suppression. Here, I
found that RAW 264.7 LeTx-treated macrophages and RAW 264.7 macrophages overexpressing HDAC8 failed to produce pro-interleukin (IL)-1β, a pro-inflammatory cytokine,
in response to the Gram-negative bacterial cell wall component lipopolysaccharide (LPS),
whereas inhibiting HDAC8 with PCI-34051 restored IL-1β and tumor necrosis factor (TNF)α production in response to LPS. Furthermore, chromatin immunoprecipitation (ChIP)quantitative real-time polymerase chain reaction (qPCR) analysis revealed that inhibiting
HDAC8 in the presence of LeTx increased H3K27Ac association with the genomic regions
of IL-1β in response to LPS. Collectively, these results suggest that HDAC8 plays a key role
in resistance to LeTx-induced pyroptosis and LeTx-induced immunosuppression, through
targeting the H3K27Ac-associated regions of BNIP3, MLN64 and IL-1β.

KEYWORDS
Bacillus anthracis, anthrax, lethal toxin, lethal toxin-induced resistance, epigenetics, histone
deacetylation, histone deacetylase 8, immunosuppression.
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ABBREVIATIONS
ASC

Apoptosis speck-like protein containing a CARD

AVA

Anthrax Vaccine Adsorbed

BH

Bcl-2 homology

BMDM

Bone marroe derived macrophage

BNIP3

BCL2/adenovirus E1B 19 kDa-interacting protein 3

BNIP3L

BNIP3-like

CARD	
  

Caspase activation and recruitment domain

ChIP

Chromatin immunoprecipitation

CMG2

Capillary morphogenesis gene 2

DMNT

DNA methyltransferase

EF

Edema factor

ERK

Extracellular signal-regulated kinase

FBS

Fetal bovine serum

GAPDH

Glyceraldehyde 3-phosphate dehydrogenase

GSH

Glutathione

H3K27Ac

Histone H3 lysine 27 acetylation

H3K27Me3

Histone H3 lysine 27 trimethylation

HAT

Histone acetyltransferase

HDAC

Histone deacetylase

IL

Interleukin

IL-1β

Interleukin-1 beta

JNK

c-Jun Amino Terminal Kinase

LF

Lethal factor

LPS

Lipopolysaccharide

MAPK

Mitogen activated protein kinase

MEK

MAPK kinase

MEKK

MAPK kinase kinase

MLN64

Metastatic lymph node 64

NF-κB

Nuclear factor kappa B

NLR

Nod-like receptor
iii

NOD

Nuclear oligomerization domain

PA

Protective antigen

PBS

Phosphate buffered saline

qPCR

Quantitative polymerase chain reaction

ROS

Reactive oxygen species

RTKs

Receptor tyrosine kinases

S. typhimurium

Salmonella enterica serovar Typhimurium

SAPK

Stress activated protein kinase

SILAC

Stable isotope labeling of amino acids in cell culture

SOS

Son of sevenless

SRM

Selected reaction monitoring

TEM8

Tumor endothelial marker 8

TIL1R

Toll-interleukin 1 receptor

TIR

Toxin-induced resistance

TLR

Toll-like receptor

TM

Transmembrane

TNF-α

Tumor necrosis factor-alpha
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CHAPTER 1

1

INTRODUCTION

1.1

Anthrax

Anthrax is often a fatal bacterial infection caused by the Gram-positive bacterium
Bacillus anthracis. B. anthracis is primarily a soil bacterium capable of producing
endospores, which are resistant to harsh environmental conditions (e.g. high heat, UV
light, disinfectants etc.), and can remain dormant for decades [1,2]. When anthrax
endospores are present in the host they are primarily phagocytosed by macrophages and
these macrophages then migrate to the draining lymph nodes and begin to germinate to
become vegetative bacteria [1,3,4]. These vegetative bacteria are then released from
macrophages, allowing for dissemination throughout the host leading to bacteremia and
septic shock. Furthermore, vegetative B. anthracis expresses virulence factors including
toxins, which lead to systemic immune paralysis, shock, and eventual death of the host
[3].
Throughout the world in regions including South and Central America, sub-Saharan
Africa, Central and Southwestern Asia, and Southern and Eastern Europe, anthrax is
found among wild and domestic animals leading to increased risk and incidence of
anthrax in humans who interact with these animals [5]. Furthermore, due to the stability
of the endospores and the deadly consequences of infection, anthrax has been exploited
as a biological weapon on multiple occasions. Anthrax spores were used during the
invasion of Manchuria in the 1940s by the Japanese army [6], in the 2001 United States
postal attack [7] and to contaminate heroin supplies in the UK in 2009/2010 [8].

1.1.1

Types of Anthrax

To date, the Centers for Disease Control and Prevention (CDC) recognizes four types of
anthrax infections: cutaneous, gastrointestinal, injectional, and inhalational [9].
Generally, the severity of anthrax infections varies with the type of anthrax. However, all
have the potential to become systemic if left untreated. Cutaneous anthrax, which occurs
when spores get into the skin via lacerations, is the most common form of infection but
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the least life threatening. It generally affects the skin and tissue surrounding the primary
infection site and may be recognized by groups of itchy blisters or bumps, followed by
the formation of a painless ulcer with black eschar [9,10]. If left untreated, death occurs
in up to 20% of infected individuals [9]. Gastrointestinal anthrax is extremely rare, but
nonetheless is caused by the ingestion of raw or undercooked meat from an infected
animal [11]. This type of anthrax can affect the upper gastrointestinal tract, stomach, and
intestines. With proper treatment about 60% of infected individuals survive. In the
absence of treatment, death rates are greater than 50% [9]. In 2009, injectional anthrax
was identified in Northern Europe by confirming B. anthracis soft tissue infections in a
total of 47 patients who injected heroin contaminated with anthrax spores [8]. Although
symptoms are similar to those of cutaneous anthrax, the infection generally occurs deeper
under the skin or in the muscle at the drug injection site [9]. Furthermore, injectional
anthrax becomes systemic more rapidly, and is extremely difficult to diagnose and treat.
Lastly, inhalational anthrax occurs when an individual breathes in B. anthracis spores,
where infection primarily begins within the lower respiratory tract and eventually
progresses throughout the rest of the body [2,10]. Inhalational anthrax is the most
threatening form of anthrax, such that if left untreated only about 1 in 10 individuals
survive. Even with treatment, only about 50% of patients survive [9].

1.1.2

Treatment and Prevention

Immediate treatment is crucial for individuals with anthrax disease, as it greatly increases
the chance of survival. According to the US Advisory Committee on Immunization
Practices, 2 months of antimicrobial therapy with FDA-approved drugs such as
ciprofloxacin, levofloxacin, and doxycycline, in addition to a 3-dose series of Anthrax
Vaccine Adsorbed (AVA) at time zero, two and four weeks post-diagnosis is
recommended for post-exposure prophylaxis (PEP) [12,13].
To date, the FDA has not approved AVA, but the vaccine could be made available under
a declared emergency. For patients with systemic anthrax, treatment should consist of
intravenous multi-antimicrobial therapy until the individual is stable, where at least one
of the drugs is a protein synthesis inhibitor and another is bactericidal [13]. Furthermore,
there are two antitoxins available, Raxibacumab and Anthrax Immune Globulin
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Intravenous (AIGIV) [13], yet to date only Raxibacumab is FDA-approved [14,15].
Raxibacumab is a monoclonal antibody that inhibits the binding of an exotoxin protein
known as protective antigen (PA) to host cell receptors, thus preventing the translocation
of the effector exotoxin proteins lethal factor (LF) and edema factor (EF) into cells.
AIGIV is polyclonal antiserum that may have direct effects against EF and LF [13].

1.2

B. anthracis Virulence Factors

B. anthracis possess two extrachromosomal plamsids, pXO1 and pXO2, which are vital
for full virulence [10]. The 184.5 kilobase pair (kbp) pXO1 plasmid encodes for three
genes that comprise anthrax toxin: pag (protective antigen, PA), lef (lethal factor, LF),
and cya (edema factor, EF) [10,16]. PA combines with either EF or LF to form two
exotoxins, edema toxin (EdTx) and lethal toxin (LeTx), respectively [10,16].
Furthermore, the 95 kbp pXO2 plasmid encodes three genes including, capB, capC, and
capA, all of which are involved in the synthesis of the polyglutamic acid capsule [17].
The exotoxins, LeTx and EdTx are primarily responsible for inhibiting the host immune
response against infection, whereas the polyglutamic acid capsule acts as an antiphagocytic agent to prevent phagocytosis of vegetative bacteria [10]. Loss of either of
these extrachromosmal plasmids results in attenuated virulence during infection [10].

1.2.1

LeTx

LeTx is the dominant virulence factor produced during anthrax infection and acts as the
primary mediator of shock and death of the infected host [18-20]. LeTx is a potent
inhibitor of a variety of cellular functions within host immune cells, such as
differentiation, antigen presentation, phagocytosis, and cytokine production [21].
Collectively, these effects contribute significantly to systemic immune paralysis [21,22].
Furthermore, LeTx causes toxemia [23-25], manifested by vascular collapse [26], and
toxic shock [27]. Interestingly, the toxic shock induced by LeTx is distinct from other
bacterial-induced shock, such that it is not mediated by a cytokine storm [21].
The cellular binding component of LeTx, PA, recognizes and binds two host receptors:
tumor endothelial marker 8 (TEM8), also known as anthrax toxin receptor 1 (ANTXR1)
[28] and capillary morphogenesis gene 2 (CMG2), also known as anthrax toxin receptor 2
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(ANTXR2) [29]. Although CMG2 is widely expressed in various tissues, TEM8 is
mainly expressed in macrophages and endothelial cells [30]. Full-length PA (PA83; 83
kDa) binds to the cellular receptors through its carboxy-terminal domain and is cleaved
by a furin-like protease, leaving the 63 kDa (PA63) cleaved form bound to the receptors
[31]. The short PA fragment (PA20; 20 kDa) detaches from PA63, allowing for
oligomerization into a heptameric or octameric ring. This processing and assembly
enable the binding of LF to the PA complex [31]. Finally, the PA63-LF complexes
triggers receptor-mediated endocytosis [32] and LF is translocated into the cytosol upon
endosome acidification [33].
The effector component of LeTx, LF, is a zinc metalloproteinase and its enzymatic
activity is crucial for its cytotoxicity [34]. LF targets and deactivates mitogen-activated
protein kinase kinases (MEKs) 1 to 4, as well as 6 and 7, through N-terminal cleavage
[35-37]. Consequently, the inactivation of MEKs interferes with the mitogen activated
protein kinase (MAPK) signaling cascade, which controls various cell functions
including proliferation, differentiation, development, immune modulation and survival
[38]. The three functional domains of LF include the N-terminal domain, which binds to
PA, the substrate-binding domain, which binds MEKs, and the proteolytic C-terminal
domain, which cleaves target substrates [39]. In summary, LF-mediated MEK cleavage
appears to play a key role in lethality through inhibiting a broad range host cell functions.

1.3

MAPK Signaling Cascade

The MAPK signaling cascade is a vital pathway in eukaryotes required for the activation
of various transcription factors that are necessary for modulating cellular activities, such
as proliferation, differentiation, and death [40]. This signaling cascade is a three-tier
phosphorelay system, which is activated through various stimuli including mitogens,
stress (e.g. toxins, DNA damage, ionizing radiation, and heat), pro-inflammatory
cytokines, as well as G-protein coupled receptor agonists [40]. The first tier of the
signaling cascade includes the MAPK kinase kinases (MEKKs). To date, there are 20
MEKKs that are differentially activated by interacting with Ras superfamily GTPases
and/or protein kinase-dependent phosphorylation downstream of cell surface receptors
[41]. Following activation, MEKKs phosphorylate and activate the second tier MAPK
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kinases (MEKs), subsequently leading to the activation of third-tier MAPKs via dual
phosphorylation of a conserved tripeptide (TxY) within the activation region by activated
MEKs [40]. The literature recognizes five MAPK families, however three families
including the extracellular-signal-regulated kinases (ERKs) 1 and 2, the Jun aminoterminal or the stress-activated protein kinases (JNKs/SAPKs), and the p38 group of
protein kinases (p38) are of primary focus in the literature [42].

1.3.1

ERK1/2

ERK1 and ERK2 (ERK1/2) are related protein kinases that modulate a broad range of
cellular functions including survival, differentiation, growth, and development through
the Ras-Raf-MEK-ERK signaling cascade [40]. Various stimuli such as mitogens and
growth factors are responsible for the activation of the ERK signal transduction pathway
via the autophosphorylation of receptor tyrosine kinases (RTKs) [43]. This
autophosphorylation event results in the recruitment of a guanine nucleotide exchange
factor (GEF), Son of Sevenless (SOS), to convert the small GTPase Ras from the inactive
state (Ras-GDP) to the active state (Ras-GTP). Ras-GTP triggers the activation of the
MEKK Raf, which is a serine/threonine kinase that phosphorylates downsteam MEKs
including, MEK1 and MEK2 [43]. Upon activation, MEK1/2 dually phosphorylates and
activates ERK1/2, thus allowing ERK to release from the multi-subunit signaling
complex in the cytoplasm and enter the nucleus to initiate gene transcription [40].

1.3.2

JNKs

The JNK family, including the JNK1, JNK2, and JNK3 (JNK1/2/3) kinases, plays a vital
role in apoptotic cell death [44], cytokine production, metabolism, and inflammation
[45,46]. Initiation of the JNK signaling transduction pathway is largely mediated through
environmental stressors such as heat, DNA damage, and oxidative stress, as well as
inflammatory cytokines and growth factors [40]. The upstream mediators responsible for
the activation of JNK signaling largely include the Rho family of GTPases, primarily Rac
and CDC42 [47]. Upon activation, MEKKs phosphorylate and activate MEK4 and
MEK7, which in turn triggers dual phosphorylation of JNK1/2/3 and promote JNK
nuclear translocation [40].
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1.3.3

p38

The family of p38 MAPKs consists of four splice variants p38-α (MAPK14), p38-β
(MAPK11), p38-γ (MAPK 12), and p38-δ (MAPK13) [40]. Activation of the p38signaling cascade is triggered by extracellular stimuli including UV light, heat, osmotic
shock, pro-inflammatory cytokines [e.g. IL-1 and TNF-α], and growth factors [e.g.
macrophage-colony stimulating factor (M-CSF)] [48]. Among the p38 family, p38-α and
p38-β are universally expressed, whereas the expression of p38-γ and p38-δ are tissue
type-dependent [48]. The entire p38 family contains a threonine-glycine-tyrosine motif
within their activation segment that is phosphorylated and activated by dual specificity
kinases, MEK3 and MEK6. Like the other MEKs, MEK3/6 activation relies on
phosphorylation by upstream MEKKs, such as MEKK1-4 [40]. p38 activation
contributes widely to biological functions, including apoptosis, cellular differentiation,
cell cycle progression, and inflammation [49,50]. In fact, its activation is essential for the
production of the pro-inflammatory cytokines IL-1β, TNF-α, and IL-6 [51], all of which
are produced by activated macrophages, which are at the forefront of the immune
response.

1.4

TLR signaling

Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) and are key
components of innate immunity. These receptors are responsible for detecting pathogen
associated molecular patterns (PAMPs) from microbes, as well as danger associated
molecular patterns (DAMPs) from injured tissue [52]. The first prototypic PRR
identified was TLR4, which recognizes the Gram-negative bacterial component
lipopolysaccharide (LPS) [53]. To date, a total of 10 TLRs have been identified in
humans and 12 in mice [52]. TLR signaling plays a crucial role during immune
responses by activating various transcription factors, through MAPK-dependent or independent pathways, which behave in combination to regulate inflammatory gene
expression [54,55]. The intracellular Toll-interleukin 1 receptor (TIL1R) domain is
crucial for TLR signaling transduction by acting as a docking site for TIL1R-containing
cytoplasmic adaptor proteins, such as the myeloid differentiation primary response gene
88 (MyD88) [56]. With the exception of TLR3, MyD88 is the primary adaptor for all
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TLRs. When TLRs are stimulated by their respective ligands, triggering TIL1R domain
activation, this activates MyD88, which subsequently leads to IL-1 receptor-associated
kinase (IRAK) 1/2/4 and TNFR-associated factor (TRAF) 6 activation. In turn,
activation of IRAK and TRAF6 activates the transforming growth factor (TAK1)
complex, which initiates MAPK and nuclear factor kappa B (NF-κB) signaling via
phosphorylation [56].

1.5

LeTx and Immune Suppression

Immune evasion and/or immunosuppression tactics are crucial for the survival and
dissemination of various pathogens. LeTx produced by B. anthracis is highly versatile in
targeting all MEKs, with the exception of MEK5 [35-37], which leads to subversion of
key immune signaling pathways necessary for innate and adaptive immune function (Fig
1.1). This immune paralysis tactic by LeTx plays a vital role in anthrax pathogenesis
[57-59], as it promotes host invasion by B. anthracis resulting in acute bacteremia and
toxemia.
Since macrophages are the initial antigen-presenting cells (APCs) responsible for the
phagocytosis and transport of B. anthracis to local lymph nodes where systemic infection
arises [57], much attention has been placed on LeTx-mediated immune suppression in
these cells. Activation of macrophages relies primarily on MAPK signaling and MAPKs
including p38 and JNKs/SAPKs are coupled to TLRs [57,60]. Activation of these TLRcoupled MAPKs is crucial for the production of various pro-inflammatory cytokines,
chemokines, and enzymes [e.g. inducible nitric oxide synthase (iNOS)] [50,61,62]. Not
surprisingly, the cleavage and subsequent inactivation of MEKs by LeTx deters
macrophage-mediated inflammation by preventing the production of inflammatory
proteins such as IL-1β, IL-6, and TNF-α [63-65]. The loss of IL-1β production is of
particular interest, as IL-1β-/- mice are more susceptible to lethality by anthrax [66].
Furthermore, LeTx also impairs antigen presentation, the production of reactive oxygen
species (ROS) such as nitric oxide, and phagocytic ability in macrophages [21,22,57].
Aside from macrophages, LeTx has also been shown to suppress other innate and
adaptive immune functions by targeting the MAPK signal transduction pathway in
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dendritic cells (DCs), neutrophils, B-lymphocytes, and T-lymphocytes. LeTx deters
immune responses in DCs by impairing cytokine production (TNF-α and IL-6), surface
activation marker expression (CD40, CD80 and CD86), antigen presentation,
phagocytosis, and bactericidal activity [21,22,67]. In neutrophils, LeTx primarily
prevents chemotaxis to the site of infection, likely by impairing their actin-based motility
[21,68]. Although adaptive immune cells play a much smaller role relative to
macrophages and DCs in the progression of acute anthrax infection, LeTx also impairs Tcell activation, chemotaxis, and cytokine responses, as well as B-cell activation,
proliferation and antibody production, particularly IgM [21,22,57,69]. Collectively,
LeTx is a potent suppressor of both innate and adaptive immune functions, thus creating
the ideal environment for B. anthracis survival and dissemination within the infected
host.
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Figure 1.1 LeTx inhibits various cellular functions through MEK inactivation.
TLRs are activated in response to infection (lightning arrow), thus activating MEKKs.
However once in the cytoplasm, anthrax lethal factor (LF) cleaves and inhibits all MEKs,
except for MEK5, preventing down-stream activation of MAPKs, which are essential for
various cellular functions.
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1.6

Pyroptosis

Pyroptosis is a type programmed cell death mediated by caspase-1 and is induced in
response to microbial infections, such as Salmonella, Legionella, and Shigella, and
various host factors [70]. Caspase-1 was originally recognized for its proteolytic
activation of pro-inflammatory cytokines, IL-1β and IL-18, however more recently it is
characterized as a defining feature of pyroptosis [70]. Pyroptic cell death involves
rupturing of the cell membrane, which leads to the liberation of pro-inflammatory
intracellular matter [70,71]. Interestingly, nuclear integrity is maintained during
pyroptosis relative to apoptotic cell death where nuclear fragmentation occurs[70].
Pyroptosis can be beneficial or detrimental to the host, either by removing intracellular
niches of intracellular pathogens [72-75], or by promoting immune evasion/dissemination
[76-79], respectively. The pyroptic cell death pathway is initiated by the activation of
innate immune receptors known as nuclear oligomorization domain and leucine-rich
repeat receptors (NLRs) [80], which are highly expressed within the cytoplasm of innate
immune cells such as macrophages.

1.6.1

NLRs and Pyroptosis

NLRs are a group of innate intracellular PRRs that respond to pathogenic attack, as well
as tissue injury [80-83]. NLRs are composed of three core structural domains: the Cterminus, which contains a leucine-rich repeat (LRR) capable of identifying conserved
ligands, the central NACHT domain that is key for NLR oligomerization and activation,
and the N-terminus effector domain [82]. The N-terminus effector domain may consist
of a pyrin domain (P), a caspase recruitment domain (C), or a baculovirus inhibitor of
apoptosis protein repeat domain (BIRD) [82]. Although cellular events such as K+ efflux,
the generation of ROS, and cathepsin B release from lysosomes are implicated in the
activation of various NLRs[84], none of these events are sufficient to activate the
receptors, and until recently NLR activation was unclear [85,86]. Current advances
demonstrated that these receptors are activated by direct interaction with their ligands.
For example, NLRX1 binds RNA, NOD1 and NOD2 are activated by peptidoglycan (a
component of bacterial cell walls) fragments, and NLRC4 is activated by flagella [87].
Following NLR activation, they oligomerize to form the inflammasome, which consists
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of NLRs, pro-caspase-1, and the adaptor protein apoptosis-associated speck-like
containing a caspase activation and recruitment domain (ASC) [81-83]. Caspase-1 is
expressed as an inactive 45-kDa zymogen and activated by an autocatalytic process in the
inflammasome complex [70,88,89]. Furthermore, activated caspase-1 is required for the
processing and release of pro-inflammatory cytokines IL-1β and IL-18, as well as
pyroptic cell death [70].
To date, there are 22 family members of NLRs in humans, which can be activated by
numerous microbial and/or viral components [90]. For example, Salmonella enterica
serovar Typhimurium (S. typhimurium) causes typhoid in humans and NLRC4 plays a
vital role in resistance during S. typhimurim infection [91,92]. NLRC4 is activated by
Salmonella flagellins or a type III secretion system component [93,94] in a Salmonella
Pathogenicity Island (SPI)-I-dependent manner [95]. Furthermore, S. typhimurim
activates NLRP3 through a SPI-II-dependent mechanism [96]. Though the activation of
these NLRs by Salmonella is protective to the host during infection [75,92,97-99], it can
also trigger septic shock [100-102]. In addition to a number of bacterial and viral
infections that trigger NLR activation, LeTx production by B. anthracis is responsible for
the activation of NLRP1 [89].

1.6.2

LeTx and Pyroptosis

Murine macrophages are divided into two groups based on their sensitivity to LeTx:
LeTx-sensitive, and LeTx-resistant. LeTx-sensitive macrophages from Balb/cJ,
C3H/HeJ, CBA/J, FVB/NJ, and SWR/J, inbred mice succumb to pyroptosis in as little as
90 minutes [21]. In contrast, LeTx-resistant macrophages from DBA/2J, AKR/J, SJL/J,
A/J, and C57BL/6J inbred mice undergo slow apoptotic death, likely due to MEK
inactivation [21]. Studies in these rodents led to the discovery of the LeTx sensitivity
allele, defined as the NLR pyrin domain–containing protein (NLRP1b; also known as
NALP1b), located on mouse chromosome 11 [103]. There have been five polymorphic
NLRP1b alleles discovered in mice to date, including NLRP1b1, NLRP1b2, NLRP1b3,
NLRP1b4, and NLRP1b5, which precisely associate with LeTx sensitivity [103]. Strains
with LeTx-susceptible macrophages possess the NLRP1b1 or NLRP1b5 alelle, where
LeTx-resistant macrophages possess alleles 2, 3 or 4 [103]. While strains harbouring a
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LeTx-sensitive NLRP1b allele showed increased host protection from B. anthracis
infection through early detection of LeTx [104], another study showed that activation of
NLRP1b enhances susceptibility to LeTx [105]. Strikingly, NLRP1b1-deficient mice
containing NLRP1b1-expressing macrophages are also susceptible to LeTx toxemia [20],
suggesting that the host is protected by B. anthracis through early detection of LeTx, but
toxic shock remains inevitable due to NLRP1b1 activation.
The activation of NLRP1b is caused by LF-dependent cleavage of the N-terminus
effector domain [106,107]. This proteolysis of NLRP1b is pertinent for inflammasome
formation, particularly pro-caspase-1 recruitment [107]. The processing of pro-caspase-1
into highly active caspase-1 is accomplished through the inflammasome platform [88].
While the inductive mechanism of pyroptosis through caspase-1 is not completely
understood, it is central for LeTx-induced pyroptosis [21]. Casapse-1 is also responsible
for the proteolytic activation of pro-inflammatory cytokines, IL-1β and IL-18. During
pyroptosis, caspase-1 induces plasma membrane pore formation that disrupts cellular ion
gradients. This leads to increased osmotic pressure, promoting water influx, swelling of
the cell and inevitable cell lysis, causing the spill of intracellular contents into the
extracellular environment [71]. Unlike apoptosis, the nuclear integrity of the cell remains
intact during pyroptic cell death [70]. Aside from NLRP1b and caspase-1 activation,
other cellular events including calcium influx [108], early mitochondrial dysfunction
[109,110], and ROS generation [111] are essential for LeTx-induced pyroptosis.
Although the precise molecular mechanisms of LeTx-induced pyroptosis remain unclear,
we linked the three mitochondrial death genes BCL2/adenovirus E1B 19 kDa-interacting
protein 3 (BNIP3), BNIP3-like (BNIP3L), and metastatic lymph node 64 protein
(MLN64) to NLRP1b/caspase-1-dependent mitochondrial dysfunction [110,112].

1.6.3

Mitochondrial Death Genes

We and others have recognized the central role of mitochondrial impairment in LeTxinduced cell death [109,110,112]. LeTx was shown to induce mitochondrial dysfunction
in murine J774.1 macrophages, manifested as a decline in mitochondrial membrane
potential and succinate dehydrogenase (SDH) activity, as well as mitochondrial swelling
[109]. Since proteasome activity is vital for caspase-1-mediated pyroptic cell death [113-
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116], inhibiting proteasome activity prevented LeTx-induced mitochondrial dysfunction
in these macrophages [109]. Furthermore, our lab previously associated the
mitochondrial death genes, BNIP3, BNIP3L, and MLN64, with caspase-1-mediated LeTxinduced mitochondrial dysfunction [110,112]. In LeTx-susceptible macrophages,
mitochondrial dysfunction included cholesterol enrichment, a rapid increase in
mitochondrial membrane potential followed by overall hypo-polarization, ROS
generation, and depletion of free glutathione (GSH) [112]. The precise mechanism of
BNIP3/BNIP3L in disrupting mitochondrial function is not known; however they are
involved in ROS generation [110,117], whereas MLN64 is implicated in cholesterol
accumulation and subsequent GSH depletion [112].
The BH (Bcl-2 homology) 3-only members of the Bcl-2 protein family contain the
BNIP3 subfamily that includes BNIP3 and BNIP3L proteins [117]. BNIP3, formerly
named NIP3, was the first member of the BNIP3 subfamily of proteins, and was
discovered via a yeast two-hybrid screen [118]. In response to cellular stress, these
proteins homodimerize within the outer mitochondrial membrane, thus initiating
programmed cell death (e.g. apoptosis) or autophagy [117]. The BH3 or the C-terminal
transmembrane (TM) domains are both responsible for regulating BNIP3/BNIP3Ldependent cell death [117]. These BH3-only proteins possess a BH3 interacting domain
(BID), which binds through its BH3 domain and activates the pro-apoptotic factors BAX
and BAK [119]. As a result, BNIP3/BNIP3L form oligomer complexes that localize to
the mitochondrial membrane and consequently lead to the release of cytochrome C into
the cytoplasm [119]. The C-terminal TM domain mainly plays a role in stabilizing dimer
formation and targeting BNIP3/BNIPL to the mitochondria to promote cell death activity
[120]. Mutational analysis of the TM domain revealed that stable dimerization is not
essential for inducing BNIP3 cell death activity [121]. However, loss of targeting BNIP3
to the mitochondria prevented mitochondrial permeability transition and ROS generation,
which are key events necessary for inducing cell death [122]. The BNIP3 N-terminal
domain has been shown to integrate into the mitochondrial membrane through its Nterminal TM regions [118]. The N-terminus of BNIP3 comprises a conserved cysteine
residue that is oriented towards the cytosol making it susceptible to oxidation [123]. As
such, under increased oxidative stress, the cysteine residue is oxidized, thus promoting
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homodimerization and pro-death activity [124]. Not surprisingly, mutating the cysteine
residue to alanine resulted in decreased homodimerization and cell death activity [125].
During cellular stress BNIP3 appears to function as a redox sensor and promotes cell
death through cooperation of the N-terminal and C-terminal TM domain [125].
MLN64, also known as StAR-related lipid transfer domain (StARD) protein 3, belongs
to a family of lipid trafficking proteins. To date, there are 15 known StARD-containing
proteins in mammals, and among them MLN64 is expressed in all tissues [126,127]. The
MLN64 protein is responsible for cholesterol transfer from the endolysosomal membrane
to the mitochondrial membrane [128-130]. It primarily locates to the membranes of late
endosomes via the N-terminal transmembrane domain termed MENTAL (MLN64 Nterminal) [128,131], whereas the C-terminal StARD signals for mitochondrial
translocation [130]. During transport, the MENTAL domain seizes endolysomal
cholesterol followed by transfer of the cholesterol to the mitochondria through interaction
with the StARD/translocation protein (TSPO; 18 kDa) on the outer mitochondrial
membrane [132,133]. Not surprisingly, increased loads and subsequent accumulation of
mitochondrial cholesterol mediated by MLN64 has been strongly linked to cell death
[134-136].

1.7

Cellular Adaptation

Macrophages are at the forefront of innate immunity and they encounter a variety of
pathogens. Consequently, they frequently adapt to various stressors in order to preserve
vigilance or moderate overwhelming inflammatory responses. For example,
macrophages pre-exposed to a sub-lethal dose of endotoxins, such as lipopolysaccharides,
become tolerant to subsequent challenges of the endotoxins [137,138]. Likewise, we and
others showed that RAW264.7 macrophages pre-exposed to a sub-lethal dose of LeTx
become refractory to subsequent high cytolytic doses of LeTx for 4-5 days
[110,112,139]. This phenomenon is termed toxin-induced resistance (TIR). We further
demonstrated that a small number of these TIR cells (~2 %) remain resistant for up to 5-6
weeks (long-term TIR). It was originally thought that these long-term TIR cells
prevented the translocation of LF into the cytosol. However, MEK cleavage by LF was
still noted, suggesting translocation into the cytosol remained unaffected [110].
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Furthermore, like RAW 264.7 wild-type macrophages, long-term TIR macrophages
showed typical NLRP1b and caspase-1 activation [110]. Overall, these findings suggest
that there were no defects in inflammasome activation, leaving the mechanism of LeTx
resistance unclear.
While inflammasome activation was normal in long-term TIR, we established key events
involved in the mediation of long-term TIR (Fig. 1.2). Genome-wide transcript analysis
of a single long-term TIR clone implicated two closely related pro-apoptotic genes,
BNIP3 and BNIP3L, in TIR [110]. Relative to wild-type, these long-term TIR
macrophages down-regulate BNIP3 and BNIP3L at both mRNA and protein levels [110].
Aside from the requirement for a fully functional inflammasome, and the up-regulation of
BNIP3 and BNIP3L, mitochondrial dysfunction is also an essential component to the
LeTx-induced pyroptotic pathway. We demonstrated that up-regulation of MLN64 is
required for mitochondrial dysfunction including, cholesterol enrichment, membrane
hyperpolarization, generation of reactive oxygen species (ROS), and depletion of GSH
[112]. However, long-term TIR macrophages showed decreased expression of MLN64
and therefore remained resistant to NLRP1b/caspase-1-induced mitochondrial
dysfunction [112].
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Figure 1.2 Key events involved in sensitivity and long-term resistance to LeTxinduced pyroptosis in macrophages.
High doses of anthrax lethal factor (LF) cleave and activate (lightning arrow) NLRP1b,
triggering casapse-1-mediated mitochondrial dysfunction and pyroptosis via BNIP3,
BNIP3L, and MLN64 expression. In contrast, sub-lethal doses of LF trigger downregulation of BNIP3, BNIP3L, and MLN64 expression, inducing long-term TIR.
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1.8

Epigenetics

Epigenetics was a term formulated by the scientist Conrad Waddington [140] and is a
cellular mechanism that inheritably regulates gene expression or cellular phenotype
without changing DNA nucleotide sequences in response to developmental and
environmental signals [141]. Two of the most studied epigenetic mechanisms include
DNA methylation and histone modifications. Although various types of histone
modifications such as, phosphorylation, ubiquitination, SUMOylation and ADPribosylation have been examined, histone phosphorylation, methylation and acetylation
often play a key role in transcriptional regulation [142].

1.8.1

Histone Modifications and Gene Expression

Histones are nuclear proteins that are responsible for the packaging and structural
organization of eukaryotic DNA into fundamental chromatin units known as nucleosomes
[143]. The nucleosome consists of a 147 base-pair DNA segment wrapped 1.65 times
around an eight-histone protein core [144]. The histone core consists of two H2A-H2B
dimers and a single H3, H4 tetramer [143]. Higher-level organization of nucleosomes is
essential for the compaction of DNA in the nucleus. Epigenetic modifications of the
four-histone proteins, regulates the availability of DNA for replication, repair, and
transcription [145,146]. These modifications include, methylation, acetylation,
SUMOylation, ADP-ribosylation, ubiquitination, and phosphorylation [143]. Most
histone modifications occur at the N-terminal tails, which are rich in positively charged
lysine residues [146]. The negatively charged DNA associates tightly with the positively
charged lysine residues, but modifications such as acetylation neutralize these charges
allowing the chromatin to "open" and promote gene transcription [147]. Various
combinations of histone modifications lead to transcriptional activation or repression
[148]. For example histone acetylation and deacetylation promote transcriptional
activation and silencing, respectively, whereas histone methylation can induce either
activation or repression. Transcriptional activation results from mono-methylation of
histone H4 lysines 20 or 5, methylation of histone H3 lysines 4, 36, or 79, as well as
acetylation at histone H3 lysines 9 or 14; whereas inactivation results from di- or trimethylation of histone H3 lysines 9 or 27 [146,149].
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1.8.1.1

Histone Acetylation and Gene Expression

Two families with antagonistic functions, histone acetyltransferases (HATs) and histone
deacetylases (HDACs) are responsible for modifying levels of histone acetylation, which
regulates gene expression (Fig. 1.3). Histone acetylation typically plays a role in the
activation of gene expression [150-152]. Acetylation at N-terminal lysine residues
decreases the association with DNA, which allows transcription factors to access the
promoter region of genes [147]. Acetylation of specific lysine residues also forms
docking sites on modified nucleosomes for specific transcriptional regulators that contain
recognition motifs such as bromodomains [153,154]. HATs are the enzymes responsible
for catalyzing acetylation by transferring acetyl groups from acetyl CoA to the histone
tails, thus inducing an open chromatin confirmation and facilitating gene transcription
[155]. The HAT family can be categorized into two classes: type A HATs, which are
primarily located in the nucleus and responsible for transcriptional activation via
acetylation of nucleosomal histones, and type B HATs, which are localized within the
cytoplasm where they acetylate recently synthesized histones prior to chromatin assembly
[156]. The majority of transcriptional regulators with acetylation activity belongs to the
type A HATs and includes, CREB (cAMP response element-binding protein)-binding
protein (CBP), E1a-binding protein p300 (p300), P300/CBP-associated factor (PCAF),
Gcn5, and TAFII250 subunit of transcription factor IID (TFIID), to name a few [156]. To
date, Hat1p is one of few type B HATs to be identified [156]. A 55-kDa polypeptide
(p55) was the first discovered type A HAT from Tetrahymena thermophile and is
analogous to Gcn5, a transcriptional co-activator from budding yeast [157]. These type
A HATs preferentially target histone H3 in vitro, however they are also capable of
acetylating histone H2B and H4 [156].
In contrast to HATs, HDACs are a family of enzymes that deacetylate histones. The
removal of acetyl groups from the histone tails, leads to tight re-association between the
positively charged lysine residues and negatively charged DNA; this reduces access of
transcription factors to gene promoter regions, which results in transcriptional repression
[150]. In addition, loss of acetylation can reduce the association of transcription factors,
which specifically bind to acetylated lysine residues to promote transcription [153,154].
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To date, there are a total of 18 HDACs belonging to two families: the zinc-dependent
family, which includes class I, II and IV, and the nicotinamide adenine dinucleotide
(NAD)-dependent family, which includes class III [150]. Class I HDACs include
HDAC1, 2, 3, and 8, which are ubiquitously expressed within the nucleus, whereas class
II HDACs include HDAC4, 5, 6, 7, 9, and 10, which are primarily located in the
cytoplasm, however they can move back and forth between the nucleus [150]. Unlike
class I HDACs, class II HDACs are not widely distributed among cell types and are
likely implicated in cell differentiation [158,159]. HDACs alone do not silence gene
expression, but they associate with other transcriptional repressors to form repressor
complexes [160]. For example, it was reported that DNA methyltransferase (DNMT) 1
and HDACs co-operate in transcriptional repression [161,162].

1.8.1.1.1

HDAC8

Unlike other class I HDACs, HDAC8, which is ~42 kDa in size, localizes in both the
cytoplasm and the nucleus, thus in part making it the most atypical protein in this class
[158,163-165]. In vitro, HDAC8 has shown deacetylase activity towards all core
histones [166-168]. One specific example includes its activity towards histone H4 lysine
16 (H4K16) [164]. Despite such findings, HDAC8’s activity towards specific histones in
vivo remain unclear [164]. In contrast, HDAC8 has various non-histone substrates. For
example, HDAC8 has been shown to interact with PP1 phosphatase, CBP, heat shock
proteins, heat shock protein 70 binding protein, cofilin and α-actin, and the human
ortholog of the yeast ever-shorter telomeres 1B [163,169-171]. Nevertheless, the role of
these HDAC8 interactions in cellular functions and TIR are not known. In addition to
these substrates, HDAC8 has also been shown to deacetylate the C-terminal end of the
transcription factor, p53 [164]. In line with these findings, a recent study demonstrated
that HDAC8 suppressed p53 expression in hepatocellular carcinoma cell lines, likely
through deacetylation of p53 at lysine382 [172]. Another study also demonstrated that
the inv(16) fusion protein, which promotes pre-leukemic populations, inhibits acetylation
of p53 by forming a complex with p53 and HDAC8 [173]. While, these data suggest a
key role for HDAC8 in cancer, the role and mechanisms of HDAC8 in infection and
immunity have not yet been examined.

22

1.8.1.2

LeTx and Histone Modifications

Epigenetic mechanisms controlling gene expression are exploited by a variety of bacterial
products, which often act by interfering with signaling transduction pathways, as well as
directly interacting in the nucleus [174]. To date, most of the histone modifications
stimulated by bacterial infection include histone acetylation/deacetylation, and histone
phosphorylation/dephosphorylation [174]. Strikingly, the production of LeTx by B.
anthracis induces dynamic histone modifications in host cells suggesting a possible
mechanism for toxin resistance and immunosuppression.
The ability of B. anthracis to circumvent the host immune response at least in part by
LeTx-mediated MEK inhibition is remarkable. However, prior to a study conducted by
Raymond et al [175], the mechanism that linked the MAPK signaling cascade inhibition
to immune gene silencing was unclear. They showed that LeTx suppressed the
expression of a neutrophil chemoattractant, IL-8 (CXCL8), in epithelial cells through
blocking p38/ERK-dependent phosphorylation of histone H3 serine 10 (H3S10), which
prevented recruitment of NF-κβ to the IL-8 and KC (keratinocyte chemoattractant)
promoters [175]. Furthermore, decreased levels of acetylation at H3K14 (H3K14Ac)
were also noted within the promoters of KC and IL-8, which is associated with a
transcription-permissive state [175].
In addition to immune suppression, LeTx also induces cell death within macrophages,
which are essential players in the first-line of defense against pathogens. Interestingly, a
Jumonji C family histone H3 lysine 27 (H3K27) demethylase, Jmjd3, was up-regulated in
LeTx resistant RAW 264.7 macrophages in response to LPS [176]. Since, Jmjd3 is
known to play a vital role in the inflammatory response by contributing to macrophage
differentiation, its expression may be crucial to the recovery of toxin exposed
macrophages [176]. Nevertheless, this study failed to show the up-regulation of Jmjd3 in
response to LeTx alone, suggesting the outcome was solely LPS-induced. As such,
further study is required to examine the role of JMJD3-dependent histone demethylation
in LeTx-resistance.
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As previously mentioned macrophages exposed to sub-lethal doses of LeTx become
refractory to subsequent cytotoxic doses, termed TIR [110,112,139]. These TIR
macrophages maintain this phenotype throughout multiple cycles of cell division. This
suggested the possibility of epigenetic reprogramming, which we have examined with a
specific focus on histone modifications. Indeed, we showed that HDAC8 expression was
positively correlated with long-term TIR [177]. Furthermore, when the H3K27 HATs,
CBP and p300, were knocked-down in RAW 264.7 macrophages and mouse primary
bone marrow derived macrophages (BMDMs), they mimicked the TIR phenotype [177].
Overall, this study revealed a strong correlation with histone deacetylation in maintaining
long-term TIR.
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Figure 1.3 Histone acetylation levels can mediate gene expression.
Histone acetyltransferases (HATs) acetylate histones, reducing association with DNA and
inducing an open chromatin confirmation to allow for access of transcriptional
machinery, and the binding of bromodomains (BRD) to acetylated histone residues, thus
promoting gene transcription. In contrast, Histone deacetylases (HDACs) deacetylate
histones, triggering tight association with DNA along with repressor complex formation,
thus preventing access of transcriptional machinery and gene transcription.
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1.9

Rationale, Hypothesis, and Objectives

RAW 264.7 macrophages are susceptible to LeTx-induced pyroptosis. However, RAW
264.7 long-term TIR macrophages down-regulated expression of the three mitochondrial
death genes, BNIP3, BNIP3L, and MLN64 [110,112], which conferred resistance to
pyroptosis. In addition to inducing pyroptosis, LeTx also causes immune suppression in
macrophages, mainly by preventing the expression of pro-inflammatory cytokine genes.
Interestingly, a gene-silencing epigenetic regulator, HDAC8, was up-regulated in longterm TIR [177]. Since histone modifications are correlated to LeTx toxicity, I
hypothesize that HDAC8 plays a fundamental role in the silencing of cytokine and
mitochondrial death genes, leading to immune suppression and resistance to pyroptosis,
respectively. Four aims were proposed to address this hypothesis:
1. Determine whether HDAC8 mediates resistance to LeTx-induced pyroptosis.
2. Identify the mechanism by which HDAC8 silences mitochondrial death gene
expression.
3. Determine whether HDAC8 plays a role in LeTx immune suppression.
4. Examine the role of HDAC8 in LeTx-mediated cytokine gene silencing.
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CHAPTER 2

2

MATERIALS AND METHODS

2.1

Cell culture and reagents

RAW 264.7 murine macrophages were cultured in DMEM containing 8% heatinactivated fetal bovine serum [FBS (Sigma-Aldrich)], 10 mM MEM non-essential amino
acid solution, 100 U/mL penicillin G sodium, 100 µg/mL streptomycin sulfate, and 1 mM
sodium pyruvate. The generation of primary bone marrow-derived macrophages
(BMDMs) was performed by Dr. Soon-Duck Ha. Briefly, bone marrow-derived cells
(BMCs) were flushed out of the leg bones (femurs and tibia) of 129/S1/Svlmj mice using
a 25.5-gauge needle and 1× phosphate buffered saline (PBS). The isolated BMCs were
then cultured in c-RPMI (Sigma-Aldrich), containing 10% heat-inactivated FBS (SigmaAldrich), 5 mM MEM non-essential amino acids solution, 1000 U/mL penicillin G
sodium, 10 mg/mL streptomycin sulfate, 5 mM sodium pyruvate, and 20 ng/mL
macrophage-colony stimulatory factor (M-CSF). The culture medium was replaced
every 2 days and after 7 days of culture ~30 million BMDMs were generated from a
single mouse. All cells were grown at 37°C in a humidified atomosphere with 5% CO2.
Long-term TIR cells were generated as previously described [110]. Briefly, RAW 264.7
macrophages were treated with a cytolytic dose of LeTx (250 ng/mL LF and 500 ng/mL
PA) for 5 h and surviving cells were plated in fresh culture medium. After two weeks,
surviving clones were individually picked and plated on a 96-well plate. Each clone was
tested for LeTx sensitivity and resistant clones were pooled and propagated. Short-term
TIR cells were generated as previously described [110]. Briefly, RAW 264.7
macrophages were treated with a sub-lethal dose of LeTx (100 ng/mL LF and 100 ng/mL
PA) for 5 h and then supplemented with fresh media overnight. The next day surviving
cells were pooled and plated onto new culture plates with fresh media. BMDM-TIR cells
were generated by Dr. Soon-Duck Ha as previously described [177]. Briefly, BMDMs
were treated with a sub-lethal dose of LeTx (100 ng/mL LF and 100 ng/mL PA) for 24 h
and surviving cells were plated onto new culture dishes with fresh media.
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Protective antigen (PA), lethal factor (LF) and Escherichia coli derived LPS were
purchased from List Biological Laboratories Inc. (California USA). The following is a
list of antibodies (Abs) used in this study. Ab against H3K27Ac was purchased from
Active Motif (California, USA). Abs for pan H3 and actin were purchased from Bio
Vision (California, USA) and Abcam Inc. (Ontario, Canada), respectively. Anti-HDAC8
and anti-HDAC3 were purchased from Epigentek. Abs against pro-IL-1β was received
from Dr. Aurigemma (NCI-FCRDC, Frederick, MD) and anti-EGFP was purchased from
Clontech Laboratories Inc. (California, USA). Abs against RNA polymerase II-phospho
S5 and RNA polymerase were purchased from Abcam Inc. (Ontario, Canada) and Active
Motif (California, USA), respectively. Rabbit IgG was purchased from Abcam (Ontario,
Canada). Please refer to table 2.1 for more detailed information on Abs used in this
study. The following is the list of chemical inhibitors used in this study: epigenetic;
panobinostat (LBH-589; Selleck), mocetinostat (Selleck), PCI-34051 (Cayman
Chemical), azacitidine (Sigma-Aldrich) and CAY10603 (Cayman Chemical), and nonepigenetic, AC-YVAD-CHO (Calbiochem). Predesigned small interfering RNA (siRNA)
oligonucleotides directed against HDAC8 (number SI1063902) were purchased from
Qiagen and siRNAs targeting mouse caspase-1 were purchased from Life Technologies
(Ambion).

2.1.1

Stable isotope labeling by amino acids in cell culture

RAW 264.7 macrophages were cultured for 7 days in SILAC DMEM (Sigma-Aldrich;
product #D9443) containing 8% dialyzed heat-inactivated FBS (Sigma Aldrich), 10 mM
MEM non-essential amino acid solution, 100 U/mL penicillin G sodium, 100 µg/mL
streptomycin sulfate, 1 mM sodium pyruvate, 0.802 mM L-leucine (Sigma-Aldrich;
product #L8912), 0.398 mM L-arginine (Sigma-Aldrich; product #A6969), and 0.798
mM L-lysine (Sigma-Aldrich; prodyct #L8662). The Lys4 (4,4,5,5-D4) isotope
(Cambridge Isotopes, DLM-2640) was used for TIR cells (0.798 mM). Per 500 mL of
SILAC DMEM, 40 mL of heat-inactivated FBS was dialyzed using cellulose membrane
dialysis tubing with a molecular weight cut-off of 12 kDa (Sigma-Aldrich; product
#D9277) in 4L of buffer (0.15M NaCl). The dialysis buffer was changed every 30
minutes for the first 3 hours and then left for an additional 9 hours. The dialyzed heat-
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inactivated FBS was then sterile-filtered using vacuum filtration (VWR; catalog # 29552016) and added to SILAC DMEM. RAW 264.7 Short-term TIR cells were generated as
described in section 2.1, however cells were labeled in respective SILAC DMEM for 5
days prior to the administration of LeTx.

2.1.2

Inhibitor treatment

For treatments with chemical inhibitors, stock solutions of panobinostat as a histone
deacetylase inhibitor (HDACi), mocetinostat as an HDACi for HDACs 1, 2, 3 and 11,
PCI-34051 as a selective HDAC8 inhibitor, CAY10603 as a selective HDAC6 inhibitor,
azacitidine as a DNA methyltransferase inhibitor (DNMTi), and AC-YVAD-CHO as a
caspase-1-inhibitor were dissolved in DMSO. The macrophages were incubated with
respective inhibitors at the indicated concentration and time as described in Figure
legends. Please see table 2.2 for more information on inhibitors used in this study.
Table 2.1 List of antibodies (Abs)
Ab

Company

Actin

Abcam

Product
Number
ab3280

eGFP

Clontech

632380

H3
H3K27Ac

3623
39135

HDAC3

Bio Vision
Active
Motif
Epigentek

A-4003

HDAC8

Epigentek

A-4008

IgG

Abcam

ab46540

Pro-IL-1β

Gift from
Dr.
Aurigemma
Active
Motif
Abcam

Pol II
Pol II
phospho
S5

Host
(Isotype)
Mouse
(IgG1)
Mouse
(IgG2a)
Rabbit
Rabbit
(serum)
Mouse
(IgG)
Mouse
(IgG)
Rabbit
(IgG)

Clonality
monoclonal

Working
Dilution
1:500

monoclonal

1:1000

polyclonal
polyclonal

1:1000
1:5000

monoclonal
monoclonal

Amount/
ChIP

3 µL
6 µg

1:500

polyclonal

6 µg
1/4/6 µg

1:1000
39097
ab5131

Mouse
(IgG)
Rabbit
(IgG)

monoclonal

1 µg

polyclonal

4 µg
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Table 2.2 List of inhibitors
Inhibitor

Company

AC-YVAD-CHO
Azacytidine
CAY10603
Mocetinostat
Panobinostat
PCI-34051

Calbiochem
Sigma-Aldrich
Cayman Chemical
Selleck
Selleck
Cayman Chemical

2.2

Product
Number
400010
A2385
13146
S1122
S1030
10444

Stock
Concentration
50 mM (DMSO)
20 mM (DMSO)
2 mM (DMSO)
50 mM (DMSO)
50 mM (DMSO)
5 mM (DMSO)

Storage
Conditions
-20°C
-20°C
-20°C
-20°C
-20°C
-20°C

Cell transfection

Transfection of RAW 264.7 macrophages and primary mouse BMDMs with siRNAs and
the pEGFP-HDAC8 plasmid was performed using the Lipofectamine RNAi Max kit and
Lipofectamine 2000 reagent (Invitrogen™), respectively, according to the manufacturer’s
instructions. 5.0×105 RAW 264.7 macrophages or 2.5×105 BMDMs were seeded on 6well plates 24 hours prior to transfection. 100 pmol for RAW264.7 cells or 150 pmol for
BMDMs of siRNAs in RNAi Max reagent were used for transfection for a total of 40
hours, unless otherwise indicated in the figure legends. Total RNAs were collected from
2×106 cells and mRNA expression levels were analyzed by quantitative polymerase chain
reaction (qPCR). Primers used for qPCR are listed in Table 2.3. Control pEFP or
pEGFP-HDAC8 plasmids were previously generated by Dr. Soon-Duck Ha. Briefly,
Full-length mouse HDAC8 cDNA (NM 027382) was amplified from a cDNA library by
PCR using primers (forward; 5′-TTGCGAATCTGATGGAGATGCCAGAGGAACCC3′, reverse; 5′-TTGCGGATCCCGGACCACATGCTTCAGATTCCC-3′) and cloned into
the pEGFP-N1 vector using EcoR I and BamH I restriction enzymes. Dr. Soon-Duck Ha
then stably transfected RAW264.7 cells with 4 µg of pEGFP or 4 µg of pEGFP-HDAC8
using Lipofectamine 2000 (Invitrogen) as described by the manufacturer’s protocol.
Stably transfected cells were selected in the presence of G418 (500 µg/ml) antibiotics for
1 week and surviving cells were pooled and further propagated under G418 selection for
an additional week.

2.3

Measurement of cell viability

1.5×105 RAW 264.7 macrophages or 0.75×105 primary BMDMs were cultured in the

31

presence or absence of LeTx in a 96-well plate for 5 hours, and 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) was added at a final concentration of 1
mg/mL. After incubating at 37 °C for an additional 3 hours, culture medium was
carefully aspirated, and 100 µL of dimethyl sulfoxide (DMSO) was added to dissolve the
crystals. Optical densities of the wells were analyzed using an automatic ELISA plate
reader (Bio-Rad) at a wavelength of 570 nm. The percentage of cell survival was
estimated based on a standard curve generated from a known number of cells and their
respective optical density (cell number versus optical density at 570 nm).

2.4

Lysate preparation and Western blot analysis

After cells were cultured for the indicated times in the presence or absence of LeTx,
inhibitors or siRNAs, 3×106 cells were collected and lysed in 150 µL of ice-cold cell lysis
buffer (20 mM MOPS, 2 mM EGTA, 5 mM EDTA, 1 mM Na3VO4, 40 mM βglycerophosphate, 30 mM sodium fluoride, and 20 mM sodium pyrophosphate, pH 7.2)
containing 1% Triton X-100, and 1/8 of a cOmplete EDTA-free protease inhibitor
cocktail tablet (Roche Applied Science; product #11873580001). Cell lysates were
incubated on ice for 10 minutes and then centrifuged at 16,100 ×g for 10 min at 4°C.
These extracts were run on 12.5% SDS gels, followed by transfer onto 0.2 µM
nitrocellulose membranes (Bio-Rad). Membranes were subsequently blocked at room
temperature (RT) for 1 hour with 5% (w/v) skim milk. Various H3, HDAC8, IL-1β,
EGFP and actin Abs were used at dilutions ranging from 1:500-1:5000 (see Table 2.1 for
working dilutions) and incubated overnight at room temperature. After washing 3 times
for 10 minutes at RT with TTBS buffer [Tris-buffered saline (50 mM Tris, 150 mM
NaCl, pH 7.6) containing 0.05% Tween 20], the secondary antibody was applied at a
1:5000 dilution and incubated for 60 min at RT. The membranes were then washed 3
times for 10 minutes with TTBS and developed using the Enhanced Chemiluminescent
Detection reagent (Thermo scientific). The NIH image J program was used to analyze
band intensity as indicated in the Figure legends.
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2.5

Histone purification

SILAC treated samples were combined in a 1:1 ratio (1.5×107 cells per sample) and
histones were acid extracted with 150 µL of 0.25 M HCl overnight with rotation at 4°C.
Samples were then centrifuged at 20, 800 ×g for 30 min and supernatants containing the
histones were collected. Supernatants were neutralized with 15 µL of 2.5 M NaOH. The
extracted histones (35 µL) were separated on 12.5 % SDS gels at a voltage of 110V for
1.5 hours. The gel was then stained with Brilliant Blue-R concentrate electrophoresis
reagent (Sigma-Aldrich). Briefly, Brilliant Blue-R solution was added to a volume just
enough to cover the gel and incubated with shaking for 2 hours. The gel was then
destained in destaining solution (45:10:45; methanol: acetic acid: ddH2O) overnight, and
for the first 3 hours the destaining solution was changed every 30 minutes. Gels were
then stored at 4°C in 5% acetic acid.

2.6

Digestion of histone H3

In-gel digestion of histone H3 (~17 kDa) was conducted using the Endoproteinase Arg-C
(Roche, Cat No. 11370529001). Digestion was carried out over four phases and all
incubations are at RT, unless stated otherwise. For the wash phase, two histone H3 gel
bands cut into cubes were incubated in 200 µL of ddH2O for 15 minutes, followed by
incubation with 100 µL of 50/50 acetonitrile (ACN)/ddH2O for 20 minutes (repeat 3×),
incubation with 100 µL ACN for 5 minutes, and incubation with 100 µL of 100 mM
NH4HCO3 for 5 minutes plus the addition of 100 µL ACN to make a 1:1 ratio for 15
minutes. The gel pieces were then dried in a speed vacuum for ~ 2 hours. For the
reduction and alkylation phase, gel pieces were incubated in a water bath at 56°C for 1
hour with 100 µL of 10 mM Dithiothreitol (DTT)/100 mM NH4HCO3 and the solution
was discarded. Next, the gel pieces were incubated in the dark for 45 minutes in 100 µL
of 5 mM iodoacetamide/100 mM NH4HCO3. The samples were then washed with 100
µL of 100 mM NH4HCO3 for 5 minutes, followed by incubation with 100 µL 50/50
ACN/ddH2O for 15 minutes, incubation with 100 µL of ACN for 5 minutes, and
incubation with 100 µL of 100 mM NH4HCO3 for 5 minutes plus the addition of 100 µL
of ACN to make a 1:1 ratio for 15 minutes. Again, gel pieces were dried in a speed
vacuum. For the digestion phase, the gel pieces were dissolved in 100 µL digestion
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buffer (100 mM Tris/HCl, 10 mM CaCl2, pH 7.6), 10 µL of activation solution (50 mM
DTT, 5 mM EDTA), and 5 µL of endoproteinase Arg-C (50 mM Tris/HCl buffer, 10 mM
CaCl2, 5 mM EDTA, pH 8.0), creating the digestion mixture (90 mM Tris/HCl buffer, 8.5
mM CaCl2, 5mM DTT, 0.5 mM EDTA, pH 7.6). Digestion was carried out at 37 °C for
18 hrs. Following digestion, the supernatant was set aside (tube B) and the extraction of
the histone H3 peptides phase was performed as follows. 30 µL of 25 mM NH4HCO3 was
added to the gel pieces (tube A) and incubated for 15 minutes, with sonication 2× for 3
minutes in an ice-filled sonication water bath. Next, 30 µL of ACN was added to tube A
to make a 1:1 solution of ACN: NH4HCO3 and incubated for 15 minutes. The
Supernatant from tube A was collected and combined with the supernatant in tube B.
The gel pieces in tube A were then incubated with 30 µL of 5% formic acid for 15
minutes, plus the same amount of ACN for an additional 15 minutes to make a 1:1 ratio
of formic acid:ACN, and then supernatants were collected and combined with tube B.
This step was then repeated one more time. The extracted peptide solution in tube B was
then dried in a speed vacuum for 4 hours. At this stage samples were given to either Drs.
Huadong Liu or Kyle Biggar in the Dr. S. Li Lab (Biochemistry, UWO) for selected
reaction monitoring mass spectrometry analysis.

2.7

Selected reaction monitoring mass spectrometry

The extracted histone H3 peptide was resuspended in 30 uL of buffer containing 95%
ddH2O, 5% ACN and 0.1% formic acid. 3ul was injected into the LC-Mass Spectrometer.
The peptides were analyzed by positive ESI-LC-MS/MS on a triple quadrupole (Q3
linear ion trap) mass spectrometer (QTRAP 4000, Applied Biosystems). A nanoAcquity
UPLC system (Waters) equipped with a C18 analytical column (1.7 µm, BEH130, 75 µm
× 200 mm and/or 75 µm × 250 mm) was used to separate the peptides at the flow rate of
300 nL/min and operating pressure of 7000 psi (at 95/5 ddH2O:ACN). Eluted peptides
were directly electrosprayed (Nanosource, ESI voltage +2000 V) into the QTRAP
instrument. Peptides were eluted using a 62 min gradient with solvents A (ddH2O, 0.1%
formic acid) and B (ACN, 0.1% formic acid) for 41 min from 5% B to 50% B, 6 min
90% B, and 10 min 5% B. The in silico protease digest patterns and the corresponding
SRM transitions were compiled with the Skyline software. Transitions that are larger
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than the precursor ion were selected on the basis of Skyline predictions and the specific
b/y ions that allow unambiguous identification of the methylated lysine sites were
included.

2.8

Chromatin immunoprecipitation

ChIP analysis was conducted as previously described [178], using H3K27Ac (Active
Motif, California), HDAC3 (Epigentek, NY), HDAC8 (Epigentek, NY), RNA
polymerase II-phospho S5 (Abcam, Ontario, Canada), and RNA polymerase II (Active
Motif, California) antibodies. 1.5×107 RAW 264.7 macrophages in 8% DMEM medium
were cross-linked by adding formaldehyde (37% stock) to a 1% final concentration for 10
minutes at RT. Adding glycine to a final concentration of 125mM stopped cross-linking.
Cells were then lysed in 160µL lysis buffer (50 mM Tris [pH 8.1], 5 mM EDTA and 1%
sodium dodecyl sulfate [SDS]) containing HaltTM protease inhibitor mixture (Thermo
Scientific). Chromatin solutions were sheared by sonication at high speed (Bioruptor
UCD-200 ultrasound sonicator, Diagenode) for 20 min resulting in DNA fragments
between 200-750 bp. Chromatin solutions were then centrifuged at 16,100 ×g for 15
minutes and supernatants were collected. The sonicated chromatin was diluted 10× in
dilution buffer (50 mM Tris [pH 8.1], 0.5% Triton X-100, 0.1 M NaCl, and 2 mM
EDTA) and 50 µL was set-aside for INPUT. After preclearing 50 µL of Protein Gconjugated Dynabeads (Invitrogen) for 1 h at 4°C, the protein G-conjugated Dynabeads
were incubated with respective antibodies (see Table 2.1 for amounts used) diluted in 200
µL of PBST [PBS-tween 20 buffer (Tween 20: 0.1%)] for 30 minutes at RT. The
remaining sonicated chromatin was then immunoprecipitated overnight at 4 oC with the
antibody-conjugated Dynabeads. The immunoprecipitates were washed 5 times for 10
minutes each at 4°C as follows: once with 1mL of Wash Buffer I (0.1% SDS, 1%
TritonX-100, 2mM EDTA, 20 mM Tris [pH 8.1], 150 mM NaCl), once with 1 mL of
Wash Buffer II (0.1% SDS, 1% TritonX-100, 2mM EDTA, 20 mM Tris [pH 8.1], 500
mM NaCl), once with 1mL of Wash Buffer III (0.25M LiCl, 1% NP-40, 1%
Deoxycholate, 1mM EDTA, 20mM Tris [pH 8.0]), and twice with 1mL of TE Buffer
(10mM Tris [pH 8.0], 1mM EDTA). Bound and INPUT chromatin were eluted with 300
µL of Elution Buffer (10 mM Tris [pH 8.1], 5 mM EDTA, 300mM NaCl, and 0.5% SDS)
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and then heated overnight at 65 oC to reverse cross-linking. DNA fragments were then
purified using QIAquick Spin columns (Qiagen) in 50 µL of DPEC water according to
the manufacturer’s instructions. 1 µL of purified DNA was then used in each ChIPqPCR analysis. For HDAC3 and HDAC8 ChIP assays, primers were designed to target
genomic sites known to be associated with H3K27Ac based on the ENCODE data base
(http://encodeproject.org/ENCODE/): BNIP3 (amplifying ~1 kb upstream of exon 1) and
MLN64 (amplifying ~1 kb upstream of exon 1). For Pol II-phospho S5 ChIP assays,
primers were designed to target the promoter regions of BNIP3, BNIP3L, MLN64,
HDAC8, and GAPDH encompassing the transcription start sites [TSS (amplifying ~150
bps upstream of the TSS)], based on the Transcriptional Regulatory Element Database
(http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process=home). For IL-1β H3K27Ac and
RNA Pol II ChIP, primers were randomly designed to amplify regions across the entire
gene and cover both Pol II- and H3K27Ac-associated sites based on ENCODE. Data are
presented as percentage of the precipitated target sequence as compared to input DNA (%
Input Method). Rabbit IgG (Abcam) was used as a background control. Sequences of
ChIP-specific primers are listed in Table 2.3.

2.9

Quantitative PCR

Briefly, total cellular RNA was isolated from 2×106 million cells using 500 µL of TRIzol
(Invitrogen) according to the manufacturer's instructions. cDNA was synthesized from 1
µg of total RNA using oligo (dT) primers and Moloney murine leukemia virus (MMuLV) reverse transcriptase (New England Biotechnology). The amplification mixture
(20 µL) contained 100 ng of cDNA, 500 nM of each specific primer set, and 10 µL of
Power SYBR Green PCR Master Mix (Applied Biosystems). mRNA expression levels
were determined by subjecting the amplification mixtures to qPCR analyses. The data
were normalized by expression of the GAPDH housekeeping gene using the delta-deltaCT method. 1 µL of purified DNAs from Pol II-phospho S5 ChIP were subjected to
qPCR using Power SYBR Green PCR Master Mix for MLN64, GAPDH, and HDAC8 or
TaqMan qPCR analysis for BNIP3 and BNIP3L, using the ZEN quencher system
(Integrated DNA Technologies) containing the qPCR mixture (50 U/ml Taq DNA
polymerase, 1 X ThermoPol reaction buffer, 200 mM 2’-deoxynucleoside 5’-
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triphosphates, 900 nM forward and reverse primers, and 250 nM double-quenched
probe). ChIP data are presented as percentage of the precipitated target sequence as
compared to input DNA (% Input Method). All qPCR analyses were performed with a
Rotor-Gene RG3000 quantitative multiplex PCR instrument (Montreal Biotech). The
PCR conditions for SYBR green qPCR were as follows: 95°C for 10 min, then 40 cycles
at 95°C for 15 sec, 58°C for 30 sec, 72°C for 25 sec, and 83°C for 15sec. The PCR
conditions for TaqMan qPCR were as follows: 95°C for 10 min, then 50 cycles at 95°C
for 15 sec, and 53°C for 45 sec. Following qPCR analyses the samples were run on a 2%
Agarose gel to confirm amplicon sizes for each specific primer set.

2.10 Enzyme-linked immunosorbent assay
RAW 264.7 macrophages (1×106 cells/1 mL of media) were cultured in the presence or
absence of various epigenetic inhibitors, LeTx, and LPS (100 ng/mL) for various times as
indicated in the Figure legends. The media was then collected and spun 16,100 ×g for 5
minutes at 4°C and supernatants were saved for ELISA. The concentrations (pg/mL) of
mouse IL-1β and TNF-α were measured using Ready-SET-Go! ELISA kits (eBioscience)
from cell culture supernatants as described by the manufacturer’s protocol.

2.11 Statistical analysis
Data is expressed as the mean ± standard error (SE). The GraphPad Prism 4.0 software
was used to determine statistical significance using the statistical test as indicated in the
figure legend. Statistical significance was defined as * P < 0.05, ** P < 0.01, and *** P <
0.001.
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Table 2.3 List of primer sequences
Analysis

Gene
BNIP3

qPCR
BNIP3L
MLN64
TNF-α
IL-1β
HDAC8
GAPDH
BNIP3
HDAC3
and
HDAC8
ChIP

MLN64
GAPDH
BNIP3

Pol IIphospho
S5 ChIP
BNIP3L

MLN64
HDAC8
GAPDH
IL-1β (1)
H3K27Ac
and Pol II IL-1β (2)
ChIP
IL-1β (3)

Primer Sequence (5’à3’)
F: GCTCCCAGACACCACAAGAT
R: TGAGAGTAGCTGTGCGCTTC
F: CCTCGTCTTCCATCCACAAT
R: GTCCCTGCTGGTATGCATCT
F: CAGGCAGTCACCGTCTTGTT
R: TGCGGTGGTGGATCAGATCT
F: CATTTGGGAACTTCTCATCC
R: CTGGAAATAGCTCCCAGAA
F: GTGGACCTTCCAGGATGAGG
R: GCTTGGGATCCACACTCTCC
F: ACGGGAAGTGTAAAGTAGCCA
R: TCCACGTAGAGAATACGGTCAAA
F: GCATTGTGGAAGGGCTCATG
R: TTGCTGTTGAAGTCGCAGGAG
F: AATCTGTCCCTCAACGGCTG
R: GTTGGTAGATGCACCAGGCT
F: CCTTCCGCTCTGAGGAGTTG
R: GACCGAACCAAAGACGGACA
F: GTTCAGACCCATCCCGTAATC
R: CAAAGGTATGCACCTCACAAC
F: CCCTTGTCCCTCAGTCCA
R: GAACCCAACTGCGACAGG
Probe: 56FAM/TGTCGCCTG/ZEN/GCCTCAGAA
CT/3IABkFQ/
F: AGCTGCCTGTGTTGTCATC
R: ACACAACAAGTCGAGTTCCC
Probe: 56FAM/TGACGTCAC/ZEN/GAAGGGAGG
GACT/3IABkFQ/
F: AATTGTCCTGAGACTCCTCTTTC
R: CAAGATCCTGACCCTAAGATAACC
F: TTGACCGTGCTACTTGTGCC
R: TGGTCCCTCGTCCAACTACA
F: GTTCAGACCCATCCCGTAATC
R: CAAAGGTATGCACCTCACAAC
F: ATGGTTCAGGGTCTCAGTTGC
R: CCCTGTGAAGGCAGAACAGA
F: TGCGGAACAAAGGTAGGCAC
R: AGAAGCCCCTGCTAACACAG
F: GAAGCTTGGCTGGAGAGGAT
R: TTCACAGCTCTTCACTTCTGC

Amplicon size
(bp)
222
161
213
298
374
145
361
100
184
145
104

104

101
153
145
151
151
125
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Analysis

Gene

IL-1β (4)
H3K27Ac
and Pol II IL-1β (5)
ChIP
IL-1β (6)
IL-1β (7)
IL-1β (8)

Primer Sequence (5’à3’)
F: AGTGACAGCACCTAAGTCCCT
R: AGTGGGTACTGGAGAGTGGTC
F: GTCAGTGTGTGGGTTGCCTTA
R: TGGCTCCTAACCTGTGGAGG
F: CAGGCAGTGAGCACATCAAG
R: GTGTCTGGTTGCCATGTACC
F: CAGGGTGGGCTCAAGCATTA
R: GGATCGGCCTACTGACCTTG
F: TTGGCCGAGGACTAAGGAGT
R: ACCTCACAAGCAGAGCACAA

Product size
(bps)
184
146
158
148
200
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CHAPTER 3

3

RESULTS

3.1

Generating TIR macrophages.

3.1.1

TIR macrophages are resistant to LeTx-induced pyroptosis.

As shown previously in our lab, RAW 264.7 macrophages exposed to a sub-lethal dose of
LeTx become resistant to subsequent lethal challenges for up to 4 days, a process termed
toxin-induced resistance (TIR) [110,112]. Furthermore, a small fraction (~2%) of these
TIR macrophages retained resistance for up to 6 weeks, which was termed long-term TIR
[110,112]. Similar to our previous reports, RAW 264.7 macrophages exposed to LeTx
for 5 hours caused ~65 % cell death in wild-type cells, but only ~20% cell death in shortterm TIR cells (Fig. 3.1A). Additionally, BMDMs pre-exposed to a sub-lethal dose of
LeTx became resistant after 24 hours. Wild-type BMDMs showed ~80% cell death,
whereas short-term TIR-BMDMs showed less than 25% cell death after a 5 hour LeTx
exposure (Fig. 3.1B). To determine whether these RAW 264.7 macrophages were
undergoing pyroptosis, as previously shown in the literature [110,112,177], cells were
pre-treated with the caspase-1 inhibitor AC-YVAD-CHO (20 µM) followed by LeTx
challenge. MTT assays revealed that LeTx-induced cell death was significantly reduced
(~40%) in wild-type cells treated with the caspase-1 inhibitor (Fig. 3.1C), suggesting that
they were in fact undergoing pyroptosis. The protection against LeTx was not 100% in
these macrophages, likely because caspase-1 may only be partially inhibited at 20 µM,
which has been reported as the optimal concentration without causing macrophage
toxicity [179].
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Figure 3.1 Short-term TIR macrophages are resistant to LeTx-induced pyroptosis.
(A) RAW 264.7 wild-type macrophages (WT) and RAW 264.7 TIR macrophages and (B)
wild-type (WT) BMDMs and TIR-BMDMs were treated with or without a lethal dose of
LeTx (PA: 500 ng/mL, LF: 250 ng/mL) for 5 hours and cell death was quantified by
MTT assays. (C) RAW 264.7 wild-type cells (WT) were treated in the presence or
absence of the caspase-1 inhibitor (20 µM) for 12 hours and then treated with or without
a lethal dose of LeTx (PA: 500 ng/mL, LF: 250 ng/mL) for 5 hours. Cell death was
measured by an MTT assay. Data are expressed as means ± SE (n ≥ 3), ** P ≤ 0.01,
***P ≤ 0.001 (Student’s T-test). Part B solely performed by Dr. Soon-Duck Ha.
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3.2
3.2.1

TIR is mediated in an HDAC8-dependent manner.
Increased HDAC8 expression is correlated with TIR.

Due to the non-permanent, but inheritable characteristics of TIR, our lab investigated
epigenetic players, including HDACs and DNMTs to examine their potential role in
maintaining the TIR phenotype. In fact, long-term TIR was found to be positively
correlated with HDAC8 mRNA expression, but not with other HDACs, including HDAC
1, 2, and 5 [177]. Although long-term TIR occurs in in vitro settings, it is more likely
that macrophages experience short-lived resistance to LeTx in vivo, as anthrax is an acute
infection, thus LeTx exposure is likely not sufficient to promote long-term resistance. As
such, HDAC8 mRNA levels were measured by qPCR in short-term TIR macrophages
and TIR-BMDMs. Like long-term TIR, short-term TIR RAW 264.7 macrophages (Fig.
3.2A) and short-term TIR-BMDMs (Fig 3.2B) showed ~2-fold and ~2.5-fold increase,
respectively, in HDAC8 mRNA levels relative to wild-type macrophages. Although
short-term TIR macrophages showed increased expression of HDAC8 at the
transcriptional level, this does not always correlate with increased protein production.
Therefore, HDAC8 protein expression was measured in short-term RAW 264.7 TIR cells
by Western blot. As shown in Figure 3.3, short-term TIR macrophages showed a greater
than 3-fold increase in HDAC8 protein expression relative to wild-type macrophages.
Overall, these results suggest that HDAC8 may play a role in maintaining the TIR
phenotype in both RAW 264.7 macrophages and BMDMs.
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Figure 3.2 Short-term TIR macrophages have increased HDAC8 mRNA levels.
(A) mRNAs from RAW 264.7 wild-type (WT) and TIR macrophages and (B) mRNAs
from wild-type (WT) BMDMs and TIR-BMDMs were prepared and analyzed for
HDAC8 expression using qPCR. GAPDH was used as a reference gene for calculating
all mRNA expression. Data are expressed as means ± SE (n ≥ 3), ** P ≤ 0.01 (Student’s
T-test). Part B solely performed by Dr. Soon-Duck Ha.
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Figure 3.3 HDAC8 protein levels are increased in RAW 264.7 short-term TIR
macrophages.
Total cell lysates were prepared from RAW 264.7 wild-type and short-term TIR
macrophages and HDAC8 protein expression was measured by Western blot (left panel).
Band intensities of HDAC8 were analyzed using the NIH image J program (right panel).
Intensities of HDAC8 bands in short-term TIR cells were expressed as fold of change
relative to those of wild-type cells. Histone H3 and actin were used for loading controls.
Data are representative images of three independent experiments. Data are expressed as
means ± SE (n=3).
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3.2.2

Inhibiting HDAC8 expression sensitizes TIR macrophages to
LeTx.

Our previous work demonstrated that treating long-term TIR macrophages with the
broad-spectrum HDAC inhibitor panobinostat or specifically knocking down HDAC8 by
siRNAs sensitized these cells to LeTx-induced pyroptosis [177]. To further determine if
HDAC8 was implicated in resistance to LeTx, short-term TIR macrophages were treated
overnight in the presence or absence of varying doses of the HDAC8-specific inhibitor
PCI-34051, and then exposed to a lethal dose of LeTx for 5 hours. As expected, shortterm TIR cells treated with PCI-34051 were sensitized to LeTx in a dose-dependent
manner (Fig. 3.4A). Additionally, short-term TIR cells were not sensitized to LeTx when
treated overnight with other HDAC inhibitors, including the HDAC6 inhibitor
CAY10603 (20 pM), or the HDAC1, 2, 3 and 11 inhibitor Mocetinostat (50 nM) (Fig.
3.4B). Furthermore, when PCI-34051 (100 nM) and the caspase-1 inhibitor AC-YVADCHO (20 µM) were used in combination, short-term TIR macrophages were no longer
sensitized by LeTx (Fig. 3.4B) and exhibited cell death levels similar to those of the
control cells (< 20%). Inhibitor concentrations for mocetinostat, CAY10603 and PCI34051 were chosen based on dose studies previously conducted in our lab [177].
Furthermore, the concentration for the caspase-1 inhibitor (AC-YVAD-CHO) was chosen
based on that reported in the literature [179].
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Figure 3.4 RAW 264.7 short-term TIR cells are sensitized to LeTx-induced
pyroptosis when treated with the HDAC8 inhibitor PCI-34051.
(A) Short-term TIR cells were treated with various concentrations of the HDAC8-specific
inhibitor PCI-34051 for 24 h. Wild-type and PCI-34051-treated cells were exposed or
not exposed to a lethal dose of LeTx (PA: 500 ng/mL, LF: 250 ng/mL) for 5 h, and cell
death was then measured by MTT assays. (B) TIR cells were treated with 3 different
HDAC inhibitors, the HDAC8 inhibitor PCI-34051 (100 nM) ± the caspase-1 inhibitor I
(20 µM), the HDAC6 inhibitor CAY10603 (20 pM), or the HDAC 1,2, 3 and 11 inhibitor
mocetinostat (50 nM) for 24 hours. Wild-type, TIR (Ctrl) and inhibitor-treated TIR cells
were exposed or not exposed to a lethal dose of LeTx (PA: 500 ng/mL, LF: 250 ng/mL)
for 5 h, and cell death was measured by MTT assays. Data are expressed as means ± SE
(n=3), * P < 0.05 and ** P < 0.01 relative to LeTx-treated TIR control (One-way Anova,
Tukey’s post-test).
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3.2.3

Knocking-down HDAC8 increases expression of the mitochondrial
death genes in TIR-BMDMs.

To date, our lab has shown three mitochondrial death genes to be correlated with LeTxinduced pyroptosis: BNIP3, BNIP3L, and MLN64, and of these genes all three are
significantly down-regulated in TIR cells [110,112,177]. Since HDAC8 was shown to be
up-regulated in long-term TIR [177], and HDACs are known to contribute to gene
silencing, we investigated whether its expression influenced suppression of the three
mitochondrial death genes in TIR. As such, when HDAC8 was knocked-down in longterm TIR cells via siRNAs, BNIP3, BNIP3L, and MLN64 mRNA levels were
significantly increased relative to the control [177]. To test this hypothesis in a more
physiologically relevant setting, HDAC8 was knocked-down in short-term TIR-BMDMs
and mRNA levels of BNIP3, BNIP3L, and MLN64 were measured by qPCR. As
expected, short-term TIR-BMDM controls (si-scramble) showed a greater than 2-fold
reduction in mRNA levels of all three mitochondrial death genes relative to wild-type
BMDMs and when treated with HDAC8 siRNAs, the mRNA levels of the mitochondrial
death genes increased to levels even greater than wild-type BMDMs (Fig. 3.5).
Collectively, the data presented in figures 3.4 and 3.5 suggest that increased HDAC8
levels suppress the expression of the three mitochondrial death genes leading to
resistance to LeTx-induced pyroptic cell death.
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Figure 3.5 Short-term TIR-BMDMs knocked down in HDAC8 show increased
expression levels of the three mitochondrial death genes BNIP3, BNIP3L and
MLN64.
Short-term TIR-BMDMs were transfected with scrambled siRNA (si-scramble) or siRNA
targeting HDAC8 (si-HDAC8) for 24 hours. The expression of BNIP3, BNIP3L, and
MLN64 was analyzed by qPCR, and levels of mRNAs were expressed as fold of change
relative to those of wild-type BMDMs transfected with scrambled siRNA for 24 hours
(dotted line). GAPDH was used as a reference gene for calculating all mRNA
expression. Data are expressed as means ± SE (n = 3). Experiment solely performed by
Dr. Soon-Duck Ha.
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3.3 HDAC8-dependent deacetylation at histone H3 lysine 27
(H3K27) mediates TIR.
3.3.1

H3K27Ac is reduced in TIR macrophages.

Histones may undergo various modifications that influence the expression of genes, such
as histone acetylation, which is generally a marker of gene activation [151,152,180].
Since HDAC8 expression was increased in long-term TIR macrophages, we examined
whether histone acetylation was decreased in these cells using Western blots. Our lab
previously showed that overall levels of histone H4 acetylation remained unchanged
between wild-type and long-term TIR cells, whereas overall levels of histone H3
acetylation were significantly lower in long-term TIR cells compared to wild-type cells
[177]. Further examination at specific H3 lysine residues revealed decreased acetylation
levels in long-term TIR cells at H3K9, H3K14, and H3K27, but of these three sites,
H3K27Ac was most significantly down-regulated in long-term TIR [177].
To further confirm and quantify the down-regulation of H3K27Ac in long-term TIR,
selected reaction monitor mass spectrometry (SRM-MS) was performed in collaboration
with Dr. Huadong Liu, Dr. Kyle Biggar, and Dr. Shawn Li in the Department of
Biochemistry, UWO, who previously used this technique to systematically map protein
lysine methylation events [181]. SRM-MS allows for the direct quantification of histone
modifications between two samples using stable isotope labeling of amino acids in cell
culture (SILAC). To quantify H3K27Ac levels, wild-type and long-term TIR
macrophages were cultured with light lysine (4,4,5,5-H4) or heavy lysine (4,4,5,5-D4),
respectively, for one week to ensure maximal lysine labeling. The same number of cells
cultured with light or heavy lysine-containing media were pooled and then processed to
extract histone H3 (Fig. 3.6). Following in-gel digestion of histone H3 by the Arg-C
endopeptidase, the quantity of H3K27Ac was analyzed by interrogating the H3K27
peptide sequence as described in Method and Materials. In silico digestion of histone H3
and the synthesis of standard peptides (Table 3.1) for the generation of the standard
unmodified peptide chromatograph (Fig. 3.7B) and the standard H3K27Ac peptide
chromatograph (Fig. 3.8B) were used to confirm the detection of the unmodified (Fig
3.7C) and acetylated H3K27 peptide (Fig 3.8C) from RAW 264.7 wild-type
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macrophages. Figure 3.7A and 3.8A are the transitions used for the detection of H3K27
and H3K27Ac, respectively. For SILAC treated samples, the transitions indicated in
figure 3.9A were used for H3K27Ac peptide confirmation. Although the same transitions
were used for both light and heavy labeled samples, the peak intensity (peak height) of
the long-term TIR sample was differentiated from the wild-type peak intensity based on a
+12 Da mass shift (m/z) in the SRM mass spectrometry spectrum. This +12 Da m/z is
due to the fact that the long-term TIR sample contains four deuterium atoms (4,4,5,5-D4)
at the three H3K27 peptide lysine residues, whereas the wild-type sample contains four
hydrogen atoms (4,4,5,5-H4) at these lysine residues. As such, based on H3K27Ac peak
intensities of the wild-type (light lysine) and long-term TIR (heavy lysine) samples,
H3K27Ac was significantly lower (~ 70%) in long-term TIR relative to wild-type
macrophages (Fig 3.9B and Fig. 3.9C).
To further examine the correlation of H3K27Ac levels in resistance, wild-type and shortterm TIR macrophages were labeled with light and heavy lysine respectively and
subjected to SRM mass spectrometry analysis. H3K27 can undergo two mutually
exclusive covalent modifications, such that at a single time it can only be methylated,
acetylated, or unmodified [182]. Therefore, given that H3K27Ac levels were
significantly lower in long-term TIR (Fig. 3.9) and unmodified H3K27 levels were ~2.5
fold greater in TIR macrophages compared to wild-type macrophages (Fig. 3.10A), I
suspected that unmodified H3K27 levels increased due to a decrease in H3K27Ac levels.
While H3K27 can also be tri-methylated, since mitochondrial death gene silencing is
involved in TIR and H3K27 tri-methylation (H3K27Me3) is a general marker for gene
suppression [183], it seems most likely for H3K27Me3 levels to increase and H3K27Ac
levels to decrease in short-term TIR. To confirm equal loading of wild-type (light)
versus short-term TIR (heavy), a peptide from histone H3 [E(73)IAQDFKTDLR(83)]
was used as a control. Quantifying unmodified H3K79 from the control peptide
confirmed that wild-type and short-term TIR samples were in fact loaded in a 1:1 ratio
(Fig. 3.10B). Based on the mutual exclusiveness of modifications at H3K27, figure 3.11
demonstrates a working model of H3K27Ac levels in short-term TIR. Further
optimization is required to specifically quantify H3K27Ac in short-term TIR by SRM
mass spectrometry.
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Figure 3.6 Stable isotope labeling of amino acids in cell culture and SRM mass
spectrometry analysis.
RAW 264.7 wild-type macrophages and long-term TIR macrophages were labeled with
light lysine (4,4,5,5-H4 L-Lysine; Lys-0) or heavy lysine (4,4,5,5-D4 L-Lysine; Lys-4),
respectively, for 7 days and pooled in a 1:1 ratio. The histones were acid extracted
overnight and run on a SDS gel for Brilliant Blue-R staining. Histone H3 (17 kDa) was
in-gel digested using the Arg-C endopeptidase and subjected to SRM mass spectrometry
for the unmodified and acetylated H3K27 peptide. The H3K27 peptide for the heavylabeled long-term TIR shows a mass shift by +12 Da relative to the light-labeled sample
and peak intensities (peak height) from the mass spectrum are used to quantify the
relative amount of H3K27/H3K27Ac peptides relative to the control (wild-type
macrophages).
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Table 3.1 In silico digestion of histone H3 and the synthesis of standard peptides for
SRM mass spectrometry.

Peptides

Modification

Sequences

1

None

NH2-KSAPATGGVKKPHR-COOH

2

H3K27Ac

NH2-K(Ac)SAPATGGVKKPHR-COOH

3

H3K36Ac

NH2-KSAPATGGVK(Ac)KPHR-COOH

4

H3K37Ac

NH2-KSAPATGGVKK(Ac)PHR-COOH
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Figure 3.7 Identification of unmodified histone H3K27 by SRM mass spectrometry.
(A) Transitions used in the experiment. (B) In-silico Arg-C digestion of histone H3 and
standard peptides were synthesized and extracted ion chromatographs (XICs) show that
the SRM transitions detected the unmodified H3K27 peptides from standard samples and
from (C) Arg-C digested histone H3 prepared from RAW264.7 wild-type macrophages.
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Figure 3.8 Identification of acetylated histone H3K27 by SRM mass spectrometry.
(A) Transitions used in the experiment. (B) In-silico Arg-C digestion of histone H3 and
standard peptides were synthesized and extracted ion chromatographs (XICs) show that
the SRM transitions detected the acetylated H3K27 peptides from standard samples and
from (C) Arg-C digested histone H3 prepared from RAW264.7 wild-type macrophages.
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Figure 3.9 Long-term TIR macrophages show decreased levels of H3K27Ac relative
to wild-type macrophages by SRM mass spectrometry.
RAW 264.7 wild-type and long-term TIR macrophages were cultured in light (4,4,5,5-H4
L-Lysine) or heavy (4,4,5,5-D4 L-Lysine) lysine-containing media, respectively, for 7
days and then pooled in a 1:1 ratio. Histone H3 was then in-gel digested using the Arg-C
endoproteinase. The liquid chromatography-coupled triple quadrupole mass spectrometer
with Q3 as a linear ion trap was used to quantify H3K27Ac by interrogating the
SAPATGGVKKPHR40 peptide from digested histone H3. The Skyline software was used
for the following data acquisition, (A) transitions used in the experiment, B) a bar graph
of the relative intensity of H3K27Ac between light (wild-type) and heavy (long-term
TIR) medium and C) the relative expression of H3K27Ac (samples were first normalized
to the peak height of the respective H3K27 peptide, then presented relative to the wildtype peptide). For panel B data are expressed as means ± SE (n=3), * P< 0.05; (Student’s
T-test) and panel C is a representative figure.
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Figure 3.10 RAW 264.7 short-term TIR macrophages show increased levels of
unmodified H3K27 by SRM mass spectrometry.
RAW 264.7 wild-type and short-term TIR macrophages were cultured in light (4,4,5,5H4 L-Lysine) or heavy (4,4,5,5-D4 L-Lysine) lysine-containing media, respectively, for 7
days and then pooled in a 1:1 ratio. Histone H3 was then in-gel digested using the Arg-C
endoproteinase. The liquid chromatography-coupled triple quadrupole mass
spectrometer with Q3 as a linear ion trap was used to quantify (A) H3K27 and (B)
H3K79 by interrogating the K27 SAPATGGVKKPHR40 peptide and the
E73IAQDFKTDLR83 peptide, respectively, from digested histone H3. The Skyline
software was used for the following data acquisition. (A) Transitions used for H3K27
(upper panel) and the intensity of H3K27 (lower panel) in wild-type and TIR
macrophages (H3K27 peak heights were normalized to wild-type). (B) Transition used
for H3K79 (upper panel) and the intensity of H3K79 (lower panel) in wild-type and TIR
macrophages (H3K79 peak heights were normalized to wild-type). Data are expressed as
means ± SE (n=2), * P< 0.05; (Student’s t-test).
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Figure 3.11 Working model of H3K27Ac levels in RAW 264.7 short-term TIR
macrophages.
H3K27 is a mutually exclusive site that can be acetylated, methylated, or unmodified.
Based on mutual the exclusiveness of H3K27 modifications and the involvement of
mitochondrial death gene silencing in short-term TIR, when unmodified H3K27 levels
increase, H3K27Ac levels should decrease, and H3K27Me3 levels should increase.
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3.3.2

HDAC8-dependent H3K27 deacetylation is involved in RAW
264.7 TIR macrophages.

Since HDACs mediate the deacetylation of histones, I next sought to examine whether
HDAC8 targets H3K27 for deacetylation in long-term TIR macrophages. Figure 3.12A
shows that treatment of long-term TIR RAW 264.7 macrophages with the broadspectrum HDAC inhibitor panobinostat (100 nM) restored H3K27Ac levels to those of
wild-type macrophages, suggesting the involvement of HDACs in H3K27 deacetylation.
To confirm if HDAC8 was one of the HDACs involved in H3K27 deacetylation, longterm TIR macrophages were transfected with scrambled siRNA or siRNA targeting
HDAC8 and Western blots were conducted to examine H3K27Ac levels. Indeed, longterm TIR cells transfected with siRNAs against HDAC8 showed significantly increased
levels of H3K27Ac (~3-fold) compared to the control (Fig. 3.12B). This data suggests
that HDAC8 is involved in H3K27 deacetylation in long-term TIR macrophages.
To further examine H3K27Ac as a possible target for HDAC8, I utilized SILAC labeling
in combination with SRM mass spectrometry analysis. Short-term TIR macrophages
were labeled with heavy lysine, whereas short-term TIR macrophages treated with PCI34051 (100 nM) were labeled with light lysine. Since long-term TIR macrophages
showed a negative correlation between HDAC8 expression and H3K27Ac levels (Fig.
3.12), I expected that short-term TIR cells treated with PCI-34051 would show increased
H3K27Ac levels relative to those of non-treated short-term TIR macrophages. Although
further optimization is required to specifically quantify H3K27Ac, unmodified H3K27
showed about a 4-fold decrease in PCI-34051-treated macrophages relative to untreated
short-term TIR macrophages (Fig. 3.13A). Given the mutual exclusiveness of H3K27
modifications, this data suggests that inhibiting HDAC8 with PCI-34051 increased
H3K27Ac levels, leading to a decrease in unmodified H3K27, and vice versa for nontreated short-term TIR. Again, to ensure equal loadings of the samples, the
E(73)IAQDFKTDLR(83) control peptide from histone H3 was used to quantify H3K79.
As expected, both the light (TIR + PCI-34051) and heavy (TIR) samples were found in a
1:1 ratio (Fig. 3.13B). Collectively, this data suggests that TIR was mediated at least in
part by HDAC8-mediated H3K27 deacetylation.
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Figure 3.12 HDAC8 targets H3K27Ac for deacetylation in long-term TIR
macrophages.
(A) RAW 264.7 wild-type macrophages, and long-term TIR macrophages treated in the
presence or absence of panobinostat (100nM; PN) for 12 hours and (B) RAW 264.7 longterm TIR macrophages treated with either scrambled (si-scramble) or HDAC8 (siHDAC8) siRNAs for 40 hours were harvested for total cell lysates and the levels of
H3K27Ac were measured by Western blot. The NIH Image J program analyzed
intensities of bands. (A) Intensities of bands in long-term TIR cells ± PN were expressed
as fold of change relative to those of wild-type cells and (B) intensities of bands in longterm TIR cells treated with si-HDAC8 were expressed as fold of change relative to longterm TIR cells treated with si-scramble. Histone H3 was used as a loading control and
data are representative images of three independent experiments. Data are expressed as
means ± SE (n=3).

si-HDAC8

H3
Long-Term TIR + PN

Long-Term TIR

Wild-type

0.0

si-scramble

H3
Arbitrary intensity unit

H3K27ac

Arbitrary intensity unit

H3K27ac
si-HDAC8

si-scramble

Long-term TIR+PN

Long-term TIR

Wild-type

70

A)

1.5

1.0

0.5

B)
Long-term TIR

Long-term TIR

4

3

2

1

0

71

Figure 3.13 Short-term TIR macrophages treated with the HDAC8-specific
inhibitor PCI-34051 show decreased levels of unmodified H3K27 by SRM mass
spectrometry.
RAW 264.7 short-term TIR macrophages and short-term TIR macrophages treated with
the HDAC8 inhibitor PCI-34051 (100 nM; 24 hours) were cultured in heavy 4,4,5,5-D4
and light L-Lysine-containing media respectively for 7 days and then pooled in a 1:1
ratio. Histone H3 was then in-gel digested using the Arg-C endoproteinase. The liquid
chromatography-coupled triple quadrupole mass spectrometer with Q3 as a linear ion trap
was used to quantify (A) H3K27 and (B) H3K79 by interrogating the K27
SAPATGGVKKPHR40 peptide and the E73IAQDFKTDLR83 peptide, respectively, from
digested histone H3. The Skyline software was used for the following data acquisition.
(A) Transitions used for H3K27 (upper panel) and the intensity of H3K27 in TIR
macrophages treated in the presence or absence of PCI-34051 (H3K27 peak heights were
normalized to TIR). (B) Transitions used for H3K79 (upper panel) and the intensity of
H3K79 in TIR macrophages treated in the presence or absence of PCI-34051 (H3K79
peak heights were normalized to the PCI-treated sample). Data are expressed as means ±
SE (n=2), * P< 0.05; (Student’s t-test).
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3.3.3

HDAC8-dependent H3K27 deacetylation is involved in the downregulation of the mitochondrial death genes in RAW 264.7 TIR
macrophages.

Previous work in our lab showed that H3K27Ac had decreased association with the
regulatory regions of the mitochondrial death genes BNIP3 (~1 kb upstream of exon 1)
and MLN64 (~1kb upstream of exon 1), but not BNIP3L in long-term TIR macrophages
[177]. Since HDAC8 appears to target H3K27 for deacetylation, I examined whether
HDAC8 was recruited to these regions of BNIP3 and MLN64 (Fig. 3.14A). Interestingly,
HDAC8 was recruited to the H3K27Ac-associated regions (primer set 1) of BNIP3 and
MLN64, but not to the promoter regions (primer set 2) of either mitochondrial death
genes (Fig. 3.14B). The control, HDAC3, was highly recruited to both the promoter and
the H3K27Ac-associated regions of BNIP3 and MLN64, but no significant differences
were detected between wild-type and long-term TIR macrophages (Fig. 3.14B).
Collectively, this data suggests that HDAC8 mediates deacetylation at the H3K27Ac
regulatory regions of BNIP3 and MLN64, thus inducing a “closed” chromatin
conformation, which leads to the suppression of BNIP3 and MLN64 expression in longterm TIR macrophages.
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Figure 3.14 Long-term TIR macrophages show increased HDAC8 recruitment at
the H3K27Ac-associated regulatory regions of BNIP3 and MLN64.
(A) Map of the primer sets targeting the H3K27Ac-associated regulatory regions
(indicated by green line) amplifying ~1000 bps upstream and amplifying core promoter
regions (indicated by red line) ~150 bps upstream of transcription start sites of BNIP3
and MLN64 in primary mouse BMDMs as indicated on ENCODE. Black boxes represent
exons. (B) Levels of HDAC8 and HDAC3 recruitments to the promoter and H3K27Acassociated regulatory regions of BNIP3 and MLN64 were analyzed by ChIP-qPCR. DNA
from RAW 264.7 wild-type and long-term TIR macrophages were sonicated, and
immunoprecipitated using antibodies against HDAC8 and HDAC3. Immunoprecipitated
DNA was analyzed by qPCR using primers targeting the promoter and H3K27Acassociated regulatory regions of BNIP3 and MLN64. Recruitment of HDAC8 and
HDAC3 to the promoter region of GAPDH was used as a control. For ChIP efficiency,
the percentage of input DNA recovered by immunoprecipitation was determined by
qPCR. Rabbit anti-IgG was used as a background control. Data are expressed as means ±
SE (n = 3); **p < 0.01 (Student’s T-test).
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3.3.4

HDAC8 limits RNA polymerase II accessibility to the
mitochondrial death gene promoters.

Due to HDAC8’s role in down-regulating the expression of the three mitochondrial death
genes, BNIP3, BNIP3L, and MLN64 in long-term TIR, I sought to examine whether
HDAC8 suppresses expression of these genes by limiting access of transcriptional
machinery to their genomic regions. I first examined the accessibility of RNA
polymerase II (Pol II) at the promoter regions of BNIP3, BNIP3L, and MLN64 in longterm TIR macrophages using ChIP-qPCR analysis. Interestingly, the binding of RNA
polymerase II to the promoter regions of these genes was significantly lower (at least 2fold) in long-term TIR macrophages than wild-type macrophages (Fig 3.15). To further
examine whether this decreased Pol II association in long-term TIR was HDAC8dependent, RAW 264.7 macrophages were stably transfected with a plasmid overexpressing HDAC8 (pEFGP-HDAC8) and then harvested for Pol II ChIP-qPCR analysis.
Interestingly, the over-expression of HDAC8 significantly reduced the access of Pol II to
the promoter regions of BNIP3, BNIP3L, and MLN64 (Fig 3.16). Surprisingly, Pol II
accessibility at the promoter of the housekeeping gene GAPDH was also reduced in longterm TIR (Fig. 3.15) and in pEGFP-HDAC8 expressing wild-type macrophages (Fig.
3.16), suggesting that GAPDH expression is also down-regulated in long-term TIR.
Since HDAC8 expression was increased in long-term TIR [177], HDAC8 was used for
Pol II ChIP-qPCR analysis as a positive control. As expected, Pol II recruitment to the
promoter of HDAC8 in long-term TIR (Fig 3.15) showed a significant increase (~2-fold)
relative to the controls. Overall, this data suggests that HDAC8 limits the accessibility of
Pol II to the promoter of the three mitochondrial death genes in long-term TIR.
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Figure 3.15 RNA polymerase II has limited accessibility to the promoter regions of
BNIP3, BNIP3L, and MLN64 in long-term TIR.
Accessibility of Pol-II to the promoter regions of BNIP3, BNIP3L, MLN64, GAPDH and
HDAC8 was analyzed by ChIP-qPCR assays. DNA prepared from RAW 264.7 wild-type
and long-term TIR macrophages was sonicated and immunoprecipitated using phosphoS5 Pol-II Abs. Power SYBR Green qPCR (for MLN64, GAPDH and HDAC8) and
TaqMan qPCR analysis using the ZEN quencher system (for BNIP3 and BNIP3L) was
used to quantify the amounts of immunoprecipitated DNA using primers and an internal
probe. ChIP efficiency is represented as the percentage of input DNA recovered by
immunoprecipitation. Rabbit anti-IgG was used as a background control. Data are
expressed as means ± SE (n = 3); *p < 0.05, **p < 0.01 (Student’s T-test).
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Figure 3.16 RNA polymerase II has limited accessibility to the promoter regions of
BNIP3, BNIP3L, and MLN64 in RAW 264.7 macrophages over-expressing HDAC8.
Accessibility of Pol-II to the promoter regions of BNIP3, BNIP3L, MLN64 and GAPDH
was analyzed by ChIP-qPCR assays (upper panel). Pol II immunoprecipitated DNA was
analyzed by qPCR. ChIP efficiency is represented as the percentage of input DNA
recovered by immunoprecipitation. Rabbit anti-IgG was used a background control. Data
are expressed as means ± SE (n = 3), *p ≤ 0.05, **p ≤ 0.01 (Student’s T-test). Total cell
lysates from RAW 264.7 macrophages stably transfected with pEGFP or pEGFP-HDAC8
were used for EGFP western blots to confirm transfection efficacy (lower panel). Actin
was used as a loading control.
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3.4 LeTx suppresses cytokine production in an HDAC8dependent manner.
In addition to inducing pyroptosis in certain subsets of murine macrophages [21], LeTx
also causes immune suppression through inactivation of the MAPK signaling pathway.
As epigenetic reprogramming is involved in macrophage activation [184], differentiation
[185-187] and tolerance [188-190], and LeTx has been shown to alter histone
modifications in a MAPK-dependent manner leading to IL-8 suppression [175], I
suspected that histone modifications involved in the maintenance of TIR might also affect
cytokine production.

3.4.1

LeTx-treated RAW 264.7 macrophages are defective in producing
IL-1β in an HDAC8-dependent manner in response to LPS.

Various studies have shown that LeTx inhibits the production of pro-inflammatory
cytokines including IL-1β, TNFα, and IL-6 in macrophages [63,191,192]. Consistent
with these studies, I found that RAW 264.7 macrophages treated with a sub-lethal dose of
LeTx are defective in the production and release of IL-1β in response to LPS when
measured by Western blot (Fig. 3.17A) or ELISA (Fig. 3.17B), respectively. Since LeTx
appears to up-regulate HDAC8 (Fig. 3.2), the next step examined whether LeTx-treated
RAW 264.7 macrophages were defective in IL-1β production in an HDAC8-dependent
manner. As such, RAW 264.7 macrophages were stably transfected with either a control
plasmid (pEGFP) or a plasmid expressing HDAC8 (pEGFP-HDAC8) and then cells were
harvested to measure pro-IL-1β production by western blot. Interestingly, RAW cells
over-expressing HDAC8 were defective in pro-IL-1β production in response to LPS (Fig.
3.17C), thus suggesting the role of HDAC8 in the regulation of cytokine production.
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Figure 3.17 LeTx-treated and over-expressing HDAC8 RAW 264.7 macrophages
are defective in IL-1β production in response to LPS.
RAW 264.7 wild-type macrophages were treated with or without a sub-lethal dose of
LeTx (PA: 100 ng/mL, LF: 100 ng/mL) for 5 hours and then fresh media was added for
overnight incubation. The following day, samples were treated with LPS for 4 hours, and
(A) production of pro-IL-1β and (B) release of IL-1β were analyzed by Western blots or
ELISA, respectively. (C) RAW264.7 macrophages stably transfected with pEGFP or
pEGFP-HDAC8 were analyzed for expression levels of pro-IL-1β by Western blots.
Data are representative images of three independent experiments. Data are expressed as
means ±SE (n=3), ** p< 0.01 (Student’s T-test). Dr. Soon-Duck Ha solely performed
parts A-C.
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3.4.2

Inhibiting HDAC8 restores the expression and production of IL-1β
and TNF-α in LeTx-treated macrophages.

To further examine HDAC8’s role in regulating cytokine production in response to LeTx,
LeTx-treated RAW 264.7 macrophages were treated with various epigenetic inhibitors,
including panobinostat (broad-spectrum HDAC inhibitor), azacitidine (DNMT inhibitor),
and mocetinostat (HDAC 1, 2, 3, and 11 inhibitor) overnight, followed by LPS
stimulation. Supernatants were then collected to measure the release of IL-1β and TNF-α
by ELISA. Interestingly, LeTx-induced immune suppression was only reversed by
panobinostat treatment, such that the levels of IL-1β (Fig. 3.18A) and TNF-α (Fig. 3.18B)
were restored to that of wild-type levels in response to LPS. To specifically confirm the
involvement of HDAC8 in regulating cytokine production, LeTx-treated RAW 264.7
macrophages were exposed to PCI-34051 overnight and then stimulated by LPS. As
expected, PCI-34051 treatment increased the mRNA expression of IL-1β (Fig. 3.19A)
and TNF-α (Fig. 3.19B) to nearly wild-type levels in response to LPS even in the
presence of LeTx. PCI-34051 did not further induce TNFα release compared to wildtype in response to LPS (Fig. 3.20), however it slightly induced IL-1β mRNA in the
presence of LPS (Fig 3.19A). Despite a slight induction of IL-1β by PCI-34051 alone,
the data collectively suggests that inhibiting HDAC8 reversed the immunosuppressed
state triggered by LeTx.
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Figure 3.18 The broad-spectrum HDAC inhibitor panobinostat (PN) restores
production of IL-1β and TNFα in response to LPS in the presence of LeTx.
RAW 264.7 wild-type macrophages were treated with or without a sub-lethal dose of
LeTx (PA: 100 ng/mL, LF: 100 ng/mL) for 5 hours then left overnight. These LeTxtreated cells were then re-plated and exposed to various epigenetic inhibitors including,
panobinostat (PN; broad-spectrum HDAC inhibitor; 1 nM), azacitidine (Az; DNMT
inhibitor; 200 nM), and mocetinostat (MO; HDAC1-3/11 inhibitor; 150 nM) for 24 hours.
Following 4 hours of LPS (100ng/mL) treatment, supernatants were collected and levels
of (A) IL-1β and (B) TNF-α were measured by ELISA. Data are expressed as means ±
SE (n=3). Bars with same letter indicate no significant difference, p > 0.05 (One-way
Anova; Tukey’s post-test). Dr. Soon-Duck Ha prepared samples for part A and B.
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Figure 3.19 The HDAC8 specific inhibitor PCI-34051 restores mRNA levels of IL1β and TNFα in response to LPS in the presence of LeTx.
RAW 264.7 wild-type macrophages were treated with or without a sub-lethal dose of
LeTx (PA: 100 ng/mL, LF: 100 ng/mL) for 5 hours then left overnight. These LeTxtreated cells were then re-plated and exposed to the HDAC8-specific inhibitor PCI-34051
(20 nM) for 24. Following 3 hours of LPS (100ng/mL) stimulation, cells were harvested
and mRNA levels of (A) IL-1β and (B) TNFα were measured relative to GAPDH using
qPCR. All samples are normalized to the mRNA expression levels of the unstimulated
wild-type macrophages. Data are expressed as means ± SE (n=3). Bars with same letter
indicate no significant difference, p > 0.05 (One-way Anova; Tukey’s post-test).
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Figure 3.20 The HDAC8 inhibitor PCI-34051 does not induce TNF-α production in
RAW 264.7 macrophages in response to LPS.
RAW 264.7 macrophages were treated in the presence or absence of the HDAC8-specific
inhibitor PCI-34051 (20 nM) for 24 hours and then treated in the presence or absence of
LPS (100 ng/mL) for 4 hours. Following LPS stimulation, supernatants were collected
and TNF-α release was measure by ELISA. Data are expressed as means ± SE (n=3),
*** p < 0.001 and N.S. (no significant difference); Two-way Anova (Bonferroni posttest).

90

TNF-α concentration (pg/mL)

N.S.
2500

***
***

2000
1500
1000
500
0

Wild-type

PCI-34051

Non-treated
LPS (100 ng/mL)

91

3.4.3

Inhibiting HDAC8 in LeTx-treated macrophages increases
H3K27Ac and Pol II association in the genomic regions of IL-1β in
response to LPS.

In long-term TIR macrophages, I showed an increased recruitment of HDAC8 to
H3K27Ac-associated regions of BNIP3 and MLN64 (Fig. 3.14), suggesting that it targets
H3K27 and silences mitochondrial death gene expression. In addition, H3K27Ac is
largely associated with active enhancers [193]. Thus, a reduction in H3K27Ac may
hinder the process of gene transcription. I suspected that HDAC8 similarly targets the
H3K27Ac-associated regions of IL-1β. Since HDAC8 was up-regulated in RAW 264.7
macrophages treated with LeTx (Fig. 3.2A), I hypothesized that LeTx decreases
H3K27Ac-association of IL-1β in response to LPS and that inhibiting HDAC8 in this
sample would restore H3K27Ac association to that of wild-type levels. To evaluate this
hypothesis, a set of 8 primers (Set 1: ~1.4 kbp upstream of exon 1, Set 2: ~350 upstream
of exon 1, Set 3: ~85 bp down stream of exon 1, Set 4: ~100 bp downstream of exon 2,
Set 5: ~50 bp upstream of exon 3, Set 6: ~100 bp upstream of exon 4, Set 7: ~170 bp
upstream of exon 6, and Set 8: ~10 bp downstream of exon 7) for H3K27Ac ChIP-qPCR
analysis was randomly designed to encompass H3K27Ac-associaion regions of IL-1β,
based on the ENCODE database (Fig. 3.21A). Interestingly, LPS-stimulated LeTxtreated macrophages showed a significant decrease (~2-fold) in H3K27Ac association in
the genomic regions of primer set 4 (~100 bp downstream of exon 2) and primer set 5
(~50 bp upstream of exon 3) compared to LPS-stimulated wild-type macrophages (Fig.
3.21B). Inhibition of HDAC8 by PCI-34051 in LPS-stimulated LeTx-treated
macrophages restored H3K27Ac-association in the genomic regions to that of LPSstimulated wild-type levels (Fig. 3.21B). Collectively, this data suggests that HDAC8
targets H3K27 for deacetylation in the intragenic region of IL-1β in LeTx-treated
macrophages, rather than the promoter region (set 1 and set 2). In contrast, inhibiting
HDAC8 restores H3K27Ac association and likely IL-1β expression.
Since PCI-34051 increased H3K27Ac association in IL-1β in LeTx-treated macrophages
(Fig. 3.21B), I also examined whether Pol II recruitment was increased to wild-type
levels at the promoter or genomic regions of IL-1β in these macrophages using Pol-II
ChIP-qPCR analysis. The same primer sets used to analyze H3K27Ac association were
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used for Pol-II ChIP-qPCR (Fig. 3.21A). Interestingly, PCI-34051 significantly
increased Pol II recruitment to the same genomic region that showed increased H3K27Ac
association (primer set 4), but not to the promoter region (set 1 and set 2) in the LPSstimulated LeTx-treated macrophages (Fig. 3.21C). Furthermore, recruitment of Pol II
across to the entire genomic/promoter regions of IL-1β was increased by PCI-34051 in
LeTx-treated macrophages, suggesting that HDAC8 inhibition restored IL-1β
transcription.
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Figure 3.21 Inhibiting HDAC8 by PCI-34051 in LeTx-treated macrophages
increases H3K27Ac and Pol II association in the genomic regions of IL-1β in
response to LPS.
(A) Map of the primer sets expanding the H3K27Ac- and Pol II-associated regions of IL1β in primary mouse BMDMs as indicated on ENCODE. The red line marks the primary
promoter region and the black boxes represent exons (E). RAW 264.7 wild-type
macrophages (WT) were treated in the presence or absence of LeTx (PA: 100 ng/mL, LF:
100 ng/mL) for 5 hours and then fresh media was added and cultures were left overnight.
The following day, cultures were treated with or without the HDAC8 inhibitor PCI34501 (20 nM) overnight and the next day were stimulated in the presence or absence of
LPS (100 ng/mL) for 3 hours. These samples were then harvested to examine the levels
of (B) H3K27Ac and (C) RNA polymerase II association to the (A) promoter and
genomic regions of IL-1β by ChIP-qPCR analysis. DNA was sonicated and
immunoprecipitated using antibodies against H3K27Ac and Pol II and analyzed by qPCR
using primers targeting the promoter and genomic regions of IL-1β. For ChIP efficiency,
the percentage of input DNA recovered by immunoprecipitation was determined by
qPCR. Rabbit anti-IgG was used as a background control. Data are expressed as means ±
SE (n = 3). Bars with same letter indicate no significant difference, p > 0.05 (One-way
Anova: Tukey’s post-test).

94

A)
1 kbp
E1

5’
Primer set

1

2

E2

3

E3

E4

5

4

E5

E6

6

E7

3’
8

7

5H3K27Ac

0.2 3-

Pol II

0.2 -

B)

6

WT

a

H3K27Ac Binding ( % Input)

LPS
5

LeTx
a

4

LeTx+LPS

a

LeTx+PCI-34051+LPS

b
b
b

3
2

b

b

bc
a

b

b
b
ab

ab
ab

ac

ab

a

a

a

a

a

a

a

a

ab

a

1

a

b

a

a

ab

ab

a

ab

a

a

a

a

set 8

set 7

set 6

set 5

set 4

set 3

set 1

set 2

0

C)

10
7.5

b

5.0

ab
a

b

b

c

c

b

bc

c
c

a

2.5

a

a

a

a

bc
bc

ab
a

ab
a

a

a

a
a

a

ab

a

a

a

ab abab
a

ac

ac

a
a

a

a

a

set 8

set 7

set 6

set 5

set 4

set 3

set 2

0.0
set 1

Pol II Binding (% Input)

WT
LPS
LeTx
LeTx+LPS
LeTx+PCI-34051+LPS

b

30

95

CHAPTER 4

4

DISCUSSION

4.1

Resistance to LeTx-induced pyroptosis is HDAC8-mediated

Previous studies conducted by us [110,112] and others [139] found that RAW 264.7
macrophages exposed to sub-lethal doses of LeTx become temporarily (~ 4 days)
refractory to subsequent cytotoxic doses, which we termed TIR. Interestingly, small
subsets of these TIR macrophages are resistant to LeTx challenges for up to 6 weeks,
known as long-term TIR [110]. Consistent with our previous studies in long-term TIR
[110,112,177], RAW 264.7 short-term TIR macrophages are resistant to pyroptic cell
death, as RAW 264.7 wild-type macrophages become resistant in a caspase-1-dependent
manner (Fig. 3.1C). Several mechanisms were suggested to be involved in TIR, such as
the activation of ERK via a MEK-independent pathway, as well as an alteration in
proteasome activity [139]. In LeTx-susceptible macrophages, Salles et al. detected a
decrease in ubiquitin-conjugated proteins, which correlated with cell death. This may be
due to increased proteasome activity, as inhibiting proteasome activity with lactacystin
restored ubiquitination levels. Furthermore, TIR macrophages showed similar levels of
protein ubiquitination compared to that of lactacystin treatment, suggesting that TIR may
be a result of reduced proteasome activity [139]. Another study showed that TIR was
linked to the up-regulation of a H3K27 demethylase, Jmjd3, in response to LPS [176].
Jmjd3 is known to play a vital role in the inflammatory response by contributing to
macrophage differentiation, and therefore its expression may be crucial to the recovery of
toxin exposed macrophages [176]. Nevertheless, this study failed to show the upregulation of Jmjd3 in response to LeTx alone, suggesting the outcome was solely LPSinduced. In addition to these suggested mechanisms, we found that three mitochondrial
death genes, BNIP3, BNIP3L, and MLN64, were down-regulated in long-term TIR
macrophages, thus preventing caspase-1-dependent mitochondrial dysfunction and
pyroptosis [110,112]. However, the mechanism leading to silencing of these three
mitochondrial death genes remained unknown. This study showed that epigenetic
reprogramming played a significant role in maintaining the TIR phenotype. Epigenetic
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modifications known to play a role in gene silencing include DNA methylation and
histone modifications (e.g. deacetylation). Although the role of DNA methylation in TIR
still remains elusive, increased HDAC8 expression is highly correlated with long-term
TIR [177]. Here, I showed that RAW 264.7 short-term TIR macrophages also had
increased HDAC8 expression at both mRNA and protein levels (Fig. 3.2 and 3.3). Since
HDAC8 expression was highly correlated with the TIR phenotype, I examined whether
inhibiting HDAC8 with PCI-34051, which has greater than 200-fold selectivity over
other HDACs [194], rendered RAW 264.7 short-term TIR macrophages sensitive to
LeTx-induced pyroptosis. Indeed, Figure 3.4 confirmed that inhibiting HDAC8 in RAW
264.7 short-term TIR macrophages sensitized them to LeTx-induced cell death.
Furthermore, the LeTx-induced cell death observed in these TIR macrophages was likely
pyroptosis as sensitization occurred in a caspase-1-dependent manner (Fig. 3.4). The
involvement of HDACs 1-3, 6, and 11 in mediating resistance to LeTx was dismissed, as
treatment with mocetinostat, an HDAC 1, 2, 3, and 11-specific inhibitor, and CAY10603,
an HDAC6-specific inhibitor, did not sensitize TIR macrophages to LeTx (Fig. 3.4B).
Strikingly, HDAC8 was crucial for the suppression of BNIP3, BNIP3L, and MLN64
expression in long-term TIR cells [177], as well as TIR-BMDMs (Fig. 3.5). Collectively,
these studies suggest that sub-lethal doses of LeTx induced HDAC8, which plays a key
role in resistance to subsequent LeTx challenges by contributing to the down-regulation
of the three mitochondrial death genes. It would be interesting to examine how HDAC8
is up-regulated in response to LeTx, as this is currently unknown. While more extensive
studies should be conducted to entirely reject the involvement of other HDACs in TIR,
HDAC8 appears to be a key regulator in determining susceptibility to LeTx-induced
pyroptosis.

4.2 TIR is mediated by an HDAC8-H3K27-dependent epigenetic
mechanism
HDAC8 is a ubiquitously expressed class I HDAC, and is the most divergent member of
this class as it can localize within both the cytoplasm and the nucleus [158,163-165].
HDAC8 has been implicated in the suppression of histocompatibility complex I genes by
the adenoviral E1A-12 protein [195], as well as p53 in hepatocellular carcinoma cell lines
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[172] and inv(16) fusion protein-positive leukemic stem cells [173]. To date, HDAC8
has been primarily studied with regards to cancer, whereas little is known about its role in
infection and immunity. As such, the involvement of HDAC8 in regulating
mitochondrial death gene expression is a novel finding [177]. In vitro, HDAC8 shows
deacetylase activity towards all core histones [166-168]. Furthermore, HDAC activities
are generally regulated by a variety of post-translational modifications, including
acetylation, ubiquitination and SUMOylation. However, the only known modification
regulating the activity of HDAC8 is phosphorylation by protein kinase A (PKA) at serine
39 (Ser39), which prevents its deacetylase function [167,196]. Although histone
substrates for HDAC8-mediated deacetylation remain unclear in vivo, it likely targets
histones H3 and H4, as activation of PKA increased their acetylation levels [167,196].
Consistent with these findings, our Western blots revealed an overall decrease in histone
H3 acetylation in long-term RAW 264.7 TIR macrophages, which show increased
HDAC8 expression [177]. Furthermore, among a wide range of acetylated histone H3
lysine residues, acetylation at H3K27 was most significantly reduced in long-term TIR
[177]. Together, these observations suggested that HDAC8 might target H3K27. While
Western blotting is a common technique used to examine the presence of a given protein
in a sample, it is non-quantitative. More specifically, it is not possible to determine how
much protein is present and the molecular weight of this protein can only be estimated
based on a protein ladder. Furthermore, the H3K27Ac antibodies used in this Western
blot experiment were polyclonal, meaning the blots may represent non-specific
interactions. Due to these constraints in Western blotting, we employed a technique
known as SRM mass spectrometry as a means to directly quantify H3K27Ac levels in
TIR.
Currently, SRM mass spectrometry is the most definitive method for identifying and
quantifying histone post-translational modifications, and is based on the detection of
multiple product ions from one or more precursor ions [181,197,198]. Furthermore, in
conjunction with stable isotope labeling of amino acids in cell culture (SILAC), SRM
mass spectrometry can quantify differentially expressed histone modifications between
two samples [197,198]. More specifically, measurements of differential H3K27Ac levels
between wild-type and long-term TIR samples can be accomplished by isotopic labeling
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of lysine residues (Fig. 3.6). In line with our previous findings [177], SILAC in
combination with SRM mass spectrometry confirmed a significant reduction of
acetylated H3K27 in long-term TIR macrophages (Fig. 3.9). Since short-term adaptation
to stressors in vivo is more likely to occur, this methodology was also applied for
comparing H3K27Ac levels between RAW 264.7 short-term TIR and wild-type
macrophages. Despite the increased sensitivity of triple quadrupole (MS/MS) systems,
our samples did not reach the lower detection limits for H3K27Ac, such that the
background noise was high relative to the signal. This prevented absolute identification
of the H3K27Ac peptide. Generally non-modified peptides are present at the highest
abundance, making them easily identifiable by MS/MS analysis. However, when
multiple combinations of modifications are possible at a single residue as for H3K9
[199], or H3K27 (Fig. 4.1), then analyses are much more complex. This is especially
relevant when trying to distinguish acetylation (+42.01 Da) from tri-methylation (+42.04
Da) at a single site or two different sites, as well as acetylation at two or more different
sites [197,199]. Unlike mass measurements, MS/MS can differentiate these posttranslational modifications under ideal circumstances via the production of unique
fragmentation ions at the N-terminal (b-ions) or C-terminal (y-ions). For example,
acetylation at the N-terminus of the H3K9 peptide can be differentiated from trimethylation at this site by the production of a b2 ion and a b2-59 ion, respectively [199].
Nonetheless, because our samples were not able to reach the lower detection limit, the
MS/MS spectrum obtained was not conclusively able to differentiate acetylated H3K27
from tri-methylated H3K27. Collectively, with our previous findings [177] and SRM
data from long-term TIR, the increase in the unmodified H3K27 peptide in short-term
TIR (Fig. 3.10) suggests that H3K27Ac decreased, based on the exclusiveness of
modifications at H3K27 (Fig 3.11). While H3K27 can also be tri-methylated, since
mitochondrial death gene silencing is involved in TIR and H3K27 tri-methylation is a
general marker for gene suppression [183], it seems most likely for H3K27Me3 levels to
increase and H3K27Ac levels to decrease in short-term TIR.
Acetylated histones are thought to be key substrates for HDACs [164] and this study
suggested acetylated H3K27 as one of HDAC8’s downstream targets. Interestingly, there
was a strong inverse correlation between HDAC8 and H3K27Ac expression.
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Specifically, treatment with the broad-spectrum HDAC inhibitor panobinostat or siRNAs
targeting HDAC8 restored H3K27Ac levels in long-term TIR to that of wild-type
macrophages (Fig. 3.12). Furthermore, reduced levels of the unmodified H3K27 peptide
in TIR macrophages treated with the HDAC8 inhibitor PCI-34051 (Fig. 3.13) suggested
an enhancement of H3K27Ac on the basis of exclusiveness at this site. H3K27Ac plays a
prominent role in promoting gene expression [200,201], and a previous study conducted
in our lab revealed that H3K27Ac was highly associated with the regulatory regions of
BNIP3 and MLN64, showing ~100- and ~40-fold increase above basal IgG levels,
respectively, in RAW 264.7 macrophages [177]. Conversely, H3K27Ac association at
these two mitochondrial death genes was significantly reduced in long-term TIR. Since
H3K27Ac is a possible HDAC8 substrate, further ChIP-qPCR analysis was conducted to
examine whether HDAC8 recruitment was increased at these sites. As expected, HDAC8
recruitment was increased at H3K27Ac-associated regions of BNIP3 and MLN64, but not
at the promoter in long-term TIR, compared to that of wild-type (Fig. 3.14). This is the
second study to show HDAC8 interaction with a DNA target; a recent study
demonstrated that HDAC8 suppresses the activity of pro-apoptotic gene Bcl-2-modifying
factor (BMF) in colon cancer cells through interacting with the promoter regions [202].
Furthermore this study revealed activation markers H3K9Ac and H3K14Ac as potential
HDAC8 targets. Consistent with these findings, we also noted a reduction in H3K9Ac
and H3K14Ac in long-term TIR [177], suggesting that HDAC8 can deacetylate multiple
lysine residues on histone H3. However, more extensive study is required to examine
whether HDAC8 targets these sites in TIR and whether H3K9Ac and H3K14Ac play a
role in mitochondrial death gene expression. In summary, increased HDAC8 recruitment
plays a key role in silencing BNIP3 and MLN64 by deacetylating H3K27 in long-term
TIR.
Histone acetylation plays a key role in gene expression through inducing an open
chromatin confirmation, thus allowing for the binding of transcription machinery such as
RNA polymerase II (Pol II). During transcription, Pol II becomes highly phosphorylated,
such that it has different phosphorylation states based on its gene location. Specifically,
within the promoter Pol II is primarily phosphorylated at serine 5 (Pol II-phospho S5),
whereas within coding regions Pol II is generally phosphorylated at serine 2 [203]. Since
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HDAC8 appears to play a key role in BNIP3, BNIP3L and MLN64 suppression in longterm TIR, I indirectly measured the transcriptional activity of these mitochondrial death
genes by examining Pol II-phospho S5 recruitment to the promoters. As expected, longterm TIR macrophages and RAW 264.7 macrophages over-expressing HDAC8 show a
significant decrease in Pol II association at the mitochondrial death gene promoters
compared to wild-type and vector controls, respectively (Fig. 3.15 and 3.16). Overall,
this data suggests that HDAC8-mediated H3K27 deacetylation promoted a closed
chromatin conformation, preventing the binding of Pol II transcriptional machinery, and
silencing BNIP3 and MLN64 expression in long-term TIR. In support of this gene
silencing mechanism, in colon cancer cells BMF expression was inhibited by promoterHDAC8 interactions, which subsequently prevented Pol II binding [202]. Also,
decreased levels of the gene activation markers H3K9Ac and H3K14Ac were correlated
with decreased BMF expression in an HDAC8-dependent manner [202]. Collectively,
this suggests that HDAC8-dependent deacetylation of H3K9Ac and H3K14Ac may play
a role in silencing BMF expression through preventing access of Pol II to the promoter
region. As such, it would be interesting to examine if HDAC8 plays a role in mediating
BNIP3L silencing via targeting H3K9Ac or H3K14Ac.
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Figure 4.1 The H3K27 peptide histone modifications.
The histone H3 lysine 27 (H3K27) peptide generated from Arg-C digestion can have a
variety of post-translational modifications, including acetylation (Ac) or mono- di- or trimethylation (Me) at lysine (K) 27, phosphorylation (P) at serine (S) 28, acetylation or
mono- di- or tri-methylation at lysine 36, and mono-methylation at lysine 37.
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4.3 LeTx-induced cytokine suppression is mediated by an
HDAC8-H3K27-dependent epigenetic mechanism
In addition to inducing pyroptic cell death in susceptible macrophages, LeTx, even at
sub-lethal doses, disrupts inflammatory immune responses. This occurs by inhibiting the
MAPK signaling cascade, which plays a vital role in several aspects of the immune
defenses [67,204]. The inactivation of MAPK signaling impairs numerous innate
immunes responses, including the production of pro-inflamamtory cytokines such as IL1β, TNF-α, IL-6, and IL-8 [63,65,175,191]. LeTx-induced inhibition of IL-1β is
particularly important, as it prevents early detection of germinating B. anthracis [104].
This immune suppressed state is the primary cause for uncontrolled proliferation of B.
anthracis within the host [57,58,204,205]. In addition, IL-1β plays a key role in
mounting immune responses against a number of other pathogenic bacteria, including
Francisella tularensis, S. typhimurium, Listeria monocytogenes, Shigella flexneri, and
Legionella pneumophila [72,97,98,104,206-208]. In line with previous studies, treatment
with a sub-lethal dose of LeTx (100 ng/mL PA and 100 ng/mL LF) in RAW 264.7
macrophages inhibited the production of IL-1β in response to LPS (Fig. 3.17A and
3.17B). TLR signaling during infection, such as stimulation of TLR4 by LPS, is crucial
for the activation of various transcription factors that behave in combination to regulate
inflammatory gene expression [54,55]. Furthermore, TLRs are coupled to MAPK
signaling cascades [60]. Therefore due to LeTx-induced MEK inactivation, it is not
surprising that LPS stimulation failed to trigger IL-1β production in LeTx-exposed
macrophages.
Since previous sections of this study revealed that HDAC8 could regulate mitochondrial
death gene expression through altering H3K27Ac levels, I further examined whether
HDAC8 played a role in LeTx-mediated cytokine gene silencing. Interestingly, RAW
264.7 macrophages over-expressing HDAC8 failed to express pro-IL-1β in response to
LPS (Fig 3.17C). In contrast, when HDAC8 was inhibited in LeTx-exposed
macrophages by the broad-spectrum HDAC inhibitor panobinostat or the HDAC8specific inhibitor PCI-34051, IL-1β/TNF-α production and mRNA expression levels were
restored to nearly the same levels as untreated macrophages in response to LPS (Fig. 3.18
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and 3.19). Unlike HDAC8 inhibition, inhibiting HDACs 1, 2, 3, and 11 with
mocetinostat or inhibition of DNMTs with azacitidine in LeTx-treated macrophages
failed to restore IL-1β and TNF-α production in response to LPS (Fig. 3.18).
Collectively, these results suggest that involvement of HDACs 1-3, and 11, and DNA
methylation in LeTx-induced IL-1β and TNF-α suppression is minimal, whereas HDAC8
likely plays a key role in the silencing of these cytokine genes. In contrast to these
findings, a recent study showed that selective inhibition of HDAC8 by ITF3056 actually
suppressed the expression of these pro-inflammatory cytokines in vitro and in vivo [209].
Nevertheless, ITF3056’s inhibitory effects were only seen at doses greater than 200 nM,
whereas at lower doses this inhibitor showed little effect or even increased cytokine
production. As presented in figure 3.20, PCI-34051 did not show any effects on TNF-α
production in response to LPS at a 20 nM dose. Additionally, further studies in our lab
showed no differences in LPS-induced TNF-α production up to doses of 1 µM
(unpublished) and over-expressing HDAC8 in RAW 264.7 macrophages showed
significantly reduced pro-IL-1β expression in response to LPS (Fig. 3.17C), suggesting
that HDAC8 functions as a negative regulator of cytokine expression, rather than a
positive regulator as implied by Li et al. [209]. Regardless, it would be advantageous to
examine whether ITF3056 has similar effects to PCI-34051 in LeTx-induced immune
suppression.
As mentioned previously, H3K27Ac is an activation marker for gene expression
[200,201] and HDAC8 was shown to regulate mitochondrial death gene expression in an
H3K27Ac-dependent manner. Therefore, I also examined whether HDAC8-mediated
H3K27Ac deacetylation was involved in LeTx-induced IL-1β suppression in response to
LPS. Although no significant differences were noted within the promoter region, LeTx
significantly decreased H3K27Ac association in response to LPS between exon 2 and
exon 3 in a PCI-34051-sensitive manner (Fig. 3.21B). These results support the idea that
HDAC8 suppresses IL-1β expression through deacetylating H3K27. Since deacetylation
promotes a closed chromatin confirmation, I examined whether LeTx prevented Pol II
recruitment to IL-1β. Interestingly, relative to LeTx, inhibiting HDAC8 in LeTx-treated
macrophages enhanced Pol II interactions in response to LPS across the entire IL-1β
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region, particularly between exon 2 and exon 3 (Fig. 3.21C) where increased H3K27Ac
association occurred. Collectively, these findings suggest the role of enhancers in
regulating IL-1β expression.
Enhancers are key regulatory elements that are capable of controlling gene expression at
variable distances from their target genes [210], and studies have shown that stimulation
of TLR4 by LPS triggers activation of numerous enhancers [211]. Although H3K4Me1
and HATs including CBP and P300 are general markers for enhancers [193,212-216], in
a given cell type H3K27Ac positive regions within H3K4Me1 positive regions define
active enhancers [193,215,217]. These enhancer elements possess binding sites for
multiple transcription factors and are capable of recruiting Pol II, leading to the
production of non-coding enhancer RNAs (eRNAs) [210]. Not surprisingly, the
production of eRNAs is dynamically induced prior to the production of protein coding
mRNAs [218], so that they can regulate mRNA production. eRNAs can promote gene
transcription via chromatin looping, allowing access of the transcriptional complex to
promoter regions of target genes [212]. Given these features of enhancer elements, as
PCI-34051 increased H3K27Ac and Pol II association within the intragenic regions of IL1β (between exon 2 and exon 3) in LeTx-treated macrophages in response to LPS (Fig.
3.21), this suggests that eRNAs may be involved in regulating its expression. However,
further studies are required to determine whether this region does in fact encode for
functioning eRNAs.

4.4
4.4.1

Future Studies
Examining the mechanism of LeTx-mediated HDAC8 upregulation

This study revealed that HDAC8 expression was up-regulated in response to LeTx in
RAW 264.7 macrophages and BMDMs in as little as 24 hours after treatment (Fig. 3.2).
However, this study failed to address whether increased HDAC8 expression also lead to
an increase in HDAC8 activity, as it is well known that protein expression does not
always correlate to catalytic activity. As such, HDAC8 activity should be measured
using a fluorometric HDAC8 activity assay kit (Abcam; product #ab156069), by
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comparing deacetylation rates of the target substrate between wild-type and LeTx-treated
(short-term TIR) samples. Since long-term TIR macrophages showed increased H3K27
deacetylation in an HDAC8-dependent manner (Fig. 3.12), this suggests that HDAC8
activity is in fact increased and specifically targets H3K27Ac. Regardless, the HDAC8
activity assay kit would validate an increase in HDAC8 activity in response to LeTx.
Next, this study also did not address how HDAC8 expression/activity was increased in
response to LeTx. Despite preliminary data showing that MAPK inhibition correlates
with the induction of HDAC8 (unpublished), LeTx also causes immune suppression via
MEK inhibition-independent pathways [219]. This suggests that LeTx may regulate
HDAC8 expression/activity independently of MAPKs. Interestingly, HDAC8 activity
was found to be regulated by intracellular potassium concentration ([K+]i), as in vitro
concentrations around 130 mM or 10 mM inhibited or induced HDAC8 activity,
respectively [220]. Since the [K+]i in most cells is greater than 100 mM [221], HDAC8
activity was thought to be minimal under normal conditions. However LeTx, as well as
other bacterial toxins, have been shown to significantly reduce [K+]i through opening K+
channels [222-228], likely enhancing HDAC8 activity. As such, RAW 264.7
macrophages cultured in various [K+] in the presence or absence of LeTx followed by
measuring HDAC8 levels would determine whether HDAC8 acts as a [K+]i sensor.
Furthermore, this study showed that HDAC8-mediated H3K27 deacetylation is at least in
part responsible for IL-1β and mitochondrial death gene silencing in macrophages.
Therefore, measuring H3K27Ac levels in the same samples used for measuring HDAC8
levels would determine whether HDAC8 acts as a [K+]i sensor that controls immune
responses by H3K27 deacetylation.

4.4.2

Examining LeTx-mediated H3K27 methylation

In addition to deacetylation at H3K27, tri-methylation at H3K27 (H3K27Me3) is also
known to cause gene silencing through a polycomb complex [183,229]. Although this
study clearly showed a role for HDAC8-mediated H3K27 deacetylation in gene silencing,
it remains unknown whether H3K27Me3 levels are affected in an HDAC8-dependent
manner. The Enhancer of Zeste Homolog 2 (EZH2), which is a vital component of the
polycomb repressive complex 2 (PRC2), is responsible for mediating methylation of
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H3K27 and promoting gene silencing [230,231]. Remarkably, a previous study showed
that the PRC2 complex was depleted by broad-spectrum HDAC inhibition [231]. Since
HDAC8 showed an inverse correlation with H3K27Ac (Fig. 3.14), it will be of interest to
examine whether components of the PRC2 complex, as well as H3K27Me3 levels were
reduced following inhibition of HDAC8 in macrophages. Furthermore, as LeTx appears
to induce HDAC8 (Fig. 3.2), we should also examine expression levels of H3K27Me3
and PRC2 components in LeTx-treated macrophages to determine if they increase.
Collectively, these experiments will provide insight as to whether LeTx/HDAC8 plays a
role in silencing IL-1β and mitochondrial death genes through inducing H3K27Me3 as a
result of H3K27 deacetylation.
Since western blot is a non-conclusive method for quantifying histone modifications, it
would be advantageous to quantify levels of H3K27Me3 by SRM mass spectrometry.
Quantifying differential H3K27Me3 levels in various macrophage samples can be
accomplished by labeling with methionine isotopes as a methyl donor for histone
methylation, followed by SRM mass spectrometry; a technique our collaborators
successfully used to map protein lysine methylation events [181]. Isotopically labeling of
the histone methyl groups within the H3K27 peptide, rather than the lysine, which was
done in this study, eliminates the challenge of differentiating H3K27Me3 and H3K27Ac,
since they will no longer be of similar mass. Furthermore, as this study failed to quantify
H3K27Ac levels by lysine labeling and SRM mass spectrometry, levels of H3K27Me3
together with levels of unmodified H3K27 (Fig. 3.10 and 3.13) would definitively
establish H3K27Ac levels in wild-type macrophages versus LeTx-treated macrophages
and LeTx-treated macrophages versus HDAC8 inhibited LeTx-treated macrophages,
based on exclusiveness at this site.

4.4.3

Examining H3K9Ac and H3K14Ac in IL-1β and mitochondrial
death gene expression

This study revealed that HDAC8-mediated H3K27 deacetylation played a key role in the
suppression of the mitochondrial death genes, BNIP3 and MLN64, likely through
preventing access of Pol II to the promoter regions. While BNIP3L also demonstrated
decreased Pol II recruitment to its promoter region in an HDAC8-dependent manner (Fig.
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3.15 and 3.16), we previously showed that it was likely not due to decreased H3K27Acassociation [177]. In addition to decreased levels of H3K27Ac in long-term TIR, there
was also a significant reduction in H3K9Ac and H3K14Ac levels [177]. Furthermore,
another study showed that BMF gene suppression partly occurred as a result of HDAC8mediated H3K9Ac and H3K14Ac deacetylation [202]. Collectively, these findings
suggest that BNIP3L suppression may be regulated by an H3K9Ac and/or H3K14Ac
HDAC8-dependent deacetylation mechanism. Unlike, H3K27Ac, H3K9Ac and
H3K14Ac associations are not available through the ENCODE database. Therefore
ChIP-seq would be the most useful technique to examine whether BNIP3L suppression is
correlated with decreased H3K9Ac and/or H3K14Ac associations in TIR. ChIP-seq data
would further determine whether a decrease in these activation markers is also associated
with BNIP3 and MLN64 suppression in TIR. Remarkably, H3K9Ac and H3K14Ac are
vital for the recruitment of the Pol II-associated TFIID to the interferon (IFN)-γ locus,
thus playing a key role in promoting immune responses [232]. As such, it would be
interesting to examine whether H3K9Ac and/or H3K14Ac show decreased association
with IL-1β in response to LeTx. If positive results are obtained, recruitment of TFIID
could be examined by ChIP-qPCR analysis at these IL-1β sites in LeTx-treated
macrophages. Collectively, these studies would provide an alternate mechanism for IL1β and mitochondrial death gene silencing.

4.4.4

Examining eRNAs in regulating IL-1β and mitochondrial death
gene expression

This study found that LeTx-induced silencing of BNIP3 and MLN64, as well as IL-1β,
occurred through the loss of H3K27Ac association in an HDAC8-dependent manner.
While H3K27Ac is a marker for active enhancers [193,215,217], it would be interesting
to examine whether these sites encode for active eRNAs. Additionally, active enhancers
are capable of recruiting Pol II and other MAPK-dependent transcription factors, such as
AP-1, NF-κB and ATF2 [212,233-236]. It appeared as though the intragenic region of
IL-1β may possess an active enhancer negatively regulated by HDAC8, since Pol II was
largely recruited to H3K27Ac-associated sites in a PCI-34051-sensitive manner (Fig.
3.21). To this end, ChIP-qPCR should be conducted to examine whether other

109

transcription factors including AP-1, NF-κB, and ATF2, are recruited to BNIP3, MLN64,
and IL-1β H3K27Ac-associated regions in an HDAC8-inhibition dependent manner.
Furthermore, a previous study revealed that extragenic enhancer regions are also capable
of regulating gene expression [236]. Interestingly, the ENCODE database identified a
highly enriched H3K27Ac area ~ 2.5 kbps upstream of the IL-1β transcription start site.
Therefore, similar experiments should be performed to examine whether this site encodes
an enhancer element. To determine the functionality of such eRNAs in BNIP3, MLN64,
and IL-1β, eRNAs could be knocked down by siRNAs and expression levels of these
genes could be measured. Collectively, these experiments will determine whether
HDAC8-H3K27Ac histone modifications regulate BNIP3, MLN64, and IL-1β expression
via enhancers.

4.5

Summary

In summary, this study addressed the role of HDAC8 mediated histone modifications in
regulating the expression of pro-inflammatory cytokines, primarily IL-1β, and the
mitochondrial death genes during pyroptosis in macrophages. LeTx appears to induce
HDAC8, which then deacetylates H3K27Ac “enhancer” gene regions of BNIP3, MLN64,
and IL-1β. While this promotes a gene-silenced state, HDAC8-inhibition restores
expression of these genes (Fig. 4.2). As such, increased H3K27Ac levels mediated by
HDAC8 inhibition may enable the recruitment of eRNA transcriptional components to
these “enhancer” regions and compensate for LeTx-induced inactivation of MAPK
signaling in macrophages.
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Figure 4.2 Working models for HDAC8-mediated silencing of BNIP3, MLN64, and
IL-1β in response to LeTx.
In response to LeTx, HDAC8 is up-regulated. HDAC8 associates with and subsequently
deacetylates H3K27Ac-associated regions of BNIP3, MLN64, and IL-1β, promoting a
closed chromatin conformation and preventing the binding of Pol II and other
transcription factors (TF) to mediate gene transcription. In contrast inhibiting HDAC8
restores H3K27Ac levels allowing the recruitment of transcriptional machinery and
enhancer-promoter interactions, thus permitting the transcription of BNIP3, MLN64, and
IL-1β.
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4.6

Significance

Overall, this study suggests that HDAC8 acts as key dual-function regulator of innate
immune responses, such that it mediates susceptibility of macrophages to pyroptosis, as
well as controlling macrophage-mediated immune signaling. NLR activation during
infection appears to have double-edged effects, such that initially activation is protective.
However, it can also lead to exacerbation of immune responses, resulting in septic shock.
With regards to anthrax, mice that harbor NLRP1b, which upon activation initiates
pyroptosis, are in fact much more susceptible to LeTx toxemia [20,103]. In addition,
inactivation of MAPK signaling is another tactic used by LeTx as a means to evade
detection by the host immune system and cause systemic infection [59]. Since LeTxinduced MEK inactivation is likely the primary virulence mechanism during anthrax
infection in humans, antagonizing HDAC8 may act as a novel therapy for restoring host
immune responses. While countless other bacteria produce virulence factors capable of
inhibiting MAPK signaling and host immune responses [237-239], HDAC8 may also be
involved in these infections, thus extending the potential of this therapeutic treatment
beyond anthrax. In contrast, when pyroptosis is responsible for promoting overt
inflammation, such as in autoinflammatory and autoimmune diseases [240-243],
activating HDAC8 may be beneficial. Collectively, aside from anthrax, manipulating
HDAC8 has therapeutic potential for treating a wide range of infectious and
inflammatory diseases.
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